$ci 2022 Q1 10-K

Concept	2022 Q1	2021 Q4	2021
Revenue	$44.01B	$45.76B	$174.1B
YoY Change	7.41%	9.39%	8.53%
Cost Of Revenue	$29.81B		$117.6B
YoY Change	9.47%		13.6%
Gross Profit	$14.19B		$56.53B
YoY Change	3.32%		-0.69%
Gross Profit Margin	32.25%		32.47%
Selling, General & Admin	$3.299B	$3.383B	$13.03B
YoY Change	0.61%	-10.46%	-7.4%
% of Gross Profit	23.25%		23.05%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$717.0M	$743.0M	$2.923B
YoY Change	0.28%	4.21%	4.32%
% of Gross Profit	5.05%		5.17%
Operating Expenses	$3.299B	$43.87B	$13.03B
YoY Change	0.61%	9.19%	-7.4%
Operating Profit	$2.167B		$7.935B
YoY Change	10.73%		-2.67%
Interest Expense	-$299.0M	-$293.0M	-$1.208B
YoY Change	-4.78%	-13.06%	-15.99%
% of Operating Profit	-13.8%		-15.22%
Other Income/Expense, Net	-$299.0M		-$1.208B
YoY Change	-4.78%		-15.99%
Pretax Income	$1.549B	$1.312B	$6.782B
YoY Change	2.38%	-75.6%	-37.6%
Income Tax	$351.0M	$179.0M	$1.367B
% Of Pretax Income	22.66%	13.64%	20.16%
Net Earnings	$1.198B	$1.116B	$5.415B
YoY Change	2.31%	-73.01%	-36.21%
Net Earnings / Revenue	2.72%	2.44%	3.11%
Basic Earnings Per Share	$3.71		$15.87
Diluted Earnings Per Share	$3.68	$3.387M	$15.73
COMMON SHARES
Basic Shares Outstanding	321.0M shares	331.4M shares
Diluted Shares Outstanding	321.3M shares		341.0M shares

Concept	2022 Q1	2021 Q4	2021
SHORT-TERM ASSETS
Cash & Short-Term Investments			$6.001B
YoY Change			-47.88%
Cash & Equivalents	$4.424B	$5.081B	$5.081B
Short-Term Investments			$920.0M
Other Short-Term Assets	$1.042B	$1.283B	$11.34B
YoY Change	-2.16%	37.96%	1119.35%
Inventory	$3.500B	$3.722B	$3.722B
Prepaid Expenses
Receivables			$15.07B
Other Receivables			$0.00
Total Short-Term Assets	$35.39B	$36.13B	$36.13B
YoY Change	38.5%	29.98%	29.98%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.089B	$3.692B	$4.143B
YoY Change	-12.03%	-12.2%	-12.91%
Goodwill	$45.80B	$45.81B
YoY Change	2.62%	2.6%
Intangibles	$33.71B	$34.10B
YoY Change	-3.1%	-3.06%
Long-Term Investments	$18.42B	$19.36B	$19.36B
YoY Change	-24.17%	-21.29%	-21.29%
Other Assets	$2.541B	$2.728B	$10.06B
YoY Change	-0.39%	1.53%
Total Long-Term Assets	$117.2B	$118.8B	$118.8B
YoY Change	-7.36%	-6.97%	-6.97%
TOTAL ASSETS
Total Short-Term Assets	$35.39B	$36.13B	$36.13B
Total Long-Term Assets	$117.2B	$118.8B	$118.8B
Total Assets	$152.6B	$154.9B	$154.9B
YoY Change	0.35%	-0.36%	-0.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.632B	$6.655B	$6.655B
YoY Change	17.59%	21.49%	21.49%
Accrued Expenses	$8.212B	$7.758B	$7.758B
YoY Change	-2.25%	-13.86%	-13.86%
Deferred Revenue
YoY Change
Short-Term Debt	$1.570B	$2.027B	$2.027B
YoY Change	31300.0%	96.8%	96.8%
Long-Term Debt Due	$603.0M	$518.0M	$518.0M
YoY Change	51.13%	-77.9%	-77.9%
Total Short-Term Liabilities	$43.66B	$43.57B	$32.27B
YoY Change	30.45%	20.96%	3.4%
LONG-TERM LIABILITIES
Long-Term Debt	$31.01B	$31.13B	$31.13B
YoY Change	-1.76%	5.35%	5.35%
Other Long-Term Liabilities	$3.346B	$3.762B	$9.749B
YoY Change	-25.4%	-18.73%	135.6%
Total Long-Term Liabilities	$3.346B	$3.762B	$40.87B
YoY Change	-25.4%	-18.73%	21.35%
TOTAL LIABILITIES
Total Short-Term Liabilities	$43.66B	$43.57B	$32.27B
Total Long-Term Liabilities	$3.346B	$3.762B	$40.87B
Total Liabilities	$106.4B	$107.7B	$107.8B
YoY Change	2.48%	2.51%	2.52%
SHAREHOLDERS EQUITY
Retained Earnings	$33.42B	$32.59B
YoY Change	13.72%	14.06%
Common Stock	$29.74B	$29.58B
YoY Change	1.65%	2.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$15.58B	$14.18B
YoY Change	68.13%	122.46%
Treasury Stock Shares		71.25M shares
Shareholders Equity	$46.09B	$47.11B	$47.11B
YoY Change
Total Liabilities & Shareholders Equity	$152.6B	$154.9B	$154.9B
YoY Change	0.35%	-0.36%	-0.36%

Concept	2022 Q1	2021 Q4	2021
OPERATING ACTIVITIES
Net Income	$1.198B	$1.116B	$5.415B
YoY Change	2.31%	-73.01%	-36.21%
Depreciation, Depletion And Amortization	$717.0M	$743.0M	$2.923B
YoY Change	0.28%	4.21%	4.32%
Cash From Operating Activities	$2.030B	$4.275B	$7.191B
YoY Change	85.73%	-16.04%	-30.52%
INVESTING ACTIVITIES
Capital Expenditures	-$288.0M	-$304.0M	-$1.154B
YoY Change	19.01%	-4.7%	5.48%
Acquisitions			$1.833B
YoY Change			1218.71%
Other Investing Activities	$6.000M	$427.0M	-$97.00M
YoY Change		-90.99%	321.74%
Cash From Investing Activities	-$324.0M	$123.0M	-$3.611B
YoY Change	-54.81%	-97.22%	-221.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$1.275B		$7.416B
YoY Change	-50.77%		102.29%
Debt Paid & Issued, Net	$0.00		$4.578B
YoY Change	-100.0%		-43.11%
Cash From Financing Activities	-$2.171B	-2.371B	-$8.212B
YoY Change	-46.41%	-49.78%	-3.76%
NET CHANGE
Cash From Operating Activities	$2.030B	4.275B	$7.191B
Cash From Investing Activities	-$324.0M	123.0M	-$3.611B
Cash From Financing Activities	-$2.171B	-2.371B	-$8.212B
Net Change In Cash	-$488.0M	2.027B	-$4.697B
YoY Change	-86.81%	-57.69%	-197.17%
FREE CASH FLOW
Cash From Operating Activities	$2.030B	$4.275B	$7.191B
Capital Expenditures	-$288.0M	-$304.0M	-$1.154B
Free Cash Flow	$2.318B	$4.579B	$8.345B
YoY Change	73.63%	-15.38%	-27.08%

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001739940
CY2021	dei	Entity File Number EntityFileNumber	001-38769
CY2019	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201712Member
CY2020	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201602Member
CY2021Q4	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities		USD
CY2020Q4	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities		USD
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		USD
CY2020	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		USD
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax		USD
CY2020	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax		USD
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax		USD
CY2020	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax		USD
CY2021	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount		USD
	us-gaap	Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount		USD
CY2021	us-gaap	Gain Loss From Components Excluded From Assessment Of Cash Flow Hedge Effectiveness Net GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet		USD
CY2020	us-gaap	Gain Loss From Components Excluded From Assessment Of Cash Flow Hedge Effectiveness Net GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet		USD
CY2021	us-gaap	Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount		USD
CY2020	us-gaap	Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount		USD
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill		USD
CY2020	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill		USD
CY2019	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill		USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.cigna.com/20211231#AccruedExpensesAndOtherLiabilities
CY2020Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.cigna.com/20211231#AccruedExpensesAndOtherLiabilities
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2021Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#DebtCurrent
CY2020Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#DebtCurrent
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligations
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligations
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.cigna.com/20211231#AccruedExpensesAndOtherLiabilities
CY2020Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://www.cigna.com/20211231#AccruedExpensesAndOtherLiabilities
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2020Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#DebtCurrent
CY2021Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#DebtCurrent
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligations
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligations
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity Registrant Name EntityRegistrantName	Cigna Corporation
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-4991898
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	900 Cottage Grove Road
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Bloomfield
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	CT
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	06002
CY2021	dei	City Area Code CityAreaCode	860
CY2021	dei	Local Phone Number LocalPhoneNumber	226-6000
CY2021	dei	Security12b Title Security12bTitle	Common Stock, Par Value $0.01
CY2021	dei	Trading Symbol TradingSymbol	CI
CY2021	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	80800000000	USD
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	320953245	shares
CY2021	dei	Auditor Name AuditorName	PricewaterhouseCoopers LLP
CY2021	dei	Auditor Location AuditorLocation	Hartford, Connecticut
CY2021	us-gaap	Premiums Earned Net PremiumsEarnedNet	41154000000	USD
CY2020	us-gaap	Premiums Earned Net PremiumsEarnedNet	42627000000	USD
CY2019	us-gaap	Premiums Earned Net PremiumsEarnedNet	39714000000	USD
CY2021	us-gaap	Net Investment Income NetInvestmentIncome	1549000000	USD
CY2020	us-gaap	Net Investment Income NetInvestmentIncome	1244000000	USD
CY2019	us-gaap	Net Investment Income NetInvestmentIncome	1390000000	USD
CY2021	us-gaap	Revenues Revenues	174078000000	USD
CY2020	us-gaap	Revenues Revenues	160401000000	USD
CY2019	us-gaap	Revenues Revenues	153566000000	USD
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	117553000000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	103484000000	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	97668000000	USD
CY2021	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	33562000000	USD
CY2020	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	32710000000	USD
CY2019	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	30819000000	USD
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	13030000000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	14072000000	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	14053000000	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1998000000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1982000000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2949000000	USD
CY2021	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	166143000000	USD
CY2020	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	152248000000	USD
CY2019	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	145489000000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	7935000000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	8153000000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	8077000000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1208000000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1438000000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1682000000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-141000000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-199000000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2000000	USD
CY2021	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	USD
CY2020	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	4203000000	USD
CY2019	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	USD
CY2021	ci	Realized Investment Gain Loss RealizedInvestmentGainLoss	196000000	USD
CY2020	ci	Realized Investment Gain Loss RealizedInvestmentGainLoss	149000000	USD
CY2019	ci	Realized Investment Gain Loss RealizedInvestmentGainLoss	177000000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6782000000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	10868000000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	6570000000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1367000000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2379000000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1450000000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	5415000000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	8489000000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	5120000000	USD
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	50000000	USD
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	31000000	USD
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	16000000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	5365000000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	8458000000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	5104000000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	15.87
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	23.17
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	13.58
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	15.73
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	22.96
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	13.44
CY2021	us-gaap	Profit Loss ProfitLoss	5415000000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	8489000000	USD
CY2021	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	19000000	USD
CY2020	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	14000000	USD
CY2019	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	11000000	USD
CY2021	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	31000000	USD
CY2020	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	17000000	USD
CY2019	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	5000000	USD
CY2021	ci	Temporary Equity Other Comprehensive Income TemporaryEquityOtherComprehensiveIncome	-14000000	USD
CY2020	ci	Temporary Equity Other Comprehensive Income TemporaryEquityOtherComprehensiveIncome	-8000000	USD
CY2019	ci	Temporary Equity Other Comprehensive Income TemporaryEquityOtherComprehensiveIncome	-5000000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	36000000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	23000000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	5120000000	USD
CY2021	ci	Other Comprehensive Income Loss Available For Sale Securities And Derivatives Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax	-215000000	USD
CY2020	ci	Other Comprehensive Income Loss Available For Sale Securities And Derivatives Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax	-75000000	USD
CY2019	ci	Other Comprehensive Income Loss Available For Sale Securities And Derivatives Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax	957000000	USD
CY2021	ci	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax Including Temporary Equity OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity	-232000000	USD
CY2020	ci	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax Including Temporary Equity OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity	252000000	USD
CY2019	ci	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax Including Temporary Equity OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity	-59000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-410000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	105000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	133000000	USD
CY2021	ci	Other Comprehensive Income Loss Net Of Tax Including Temporary Equity OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity	-37000000	USD
CY2020	ci	Other Comprehensive Income Loss Net Of Tax Including Temporary Equity OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity	72000000	USD
CY2019	ci	Other Comprehensive Income Loss Net Of Tax Including Temporary Equity OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity	765000000	USD
CY2021	ci	Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest Including Temporary Equity ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity	5378000000	USD
CY2020	ci	Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest Including Temporary Equity ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity	8561000000	USD
CY2019	ci	Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest Including Temporary Equity ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity	5885000000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	11000000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5342000000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	8538000000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5874000000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5081000000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10182000000	USD
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	920000000	USD
CY2020Q4	us-gaap	Short Term Investments ShortTermInvestments	1331000000	USD
CY2021Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	15071000000	USD
CY2020Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	12191000000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	3722000000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	3165000000	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1283000000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	930000000	USD
CY2021Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	10057000000	USD
CY2020Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	36134000000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	27799000000	USD
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	18438000000	USD
CY2020Q4	us-gaap	Long Term Investments LongTermInvestments	23262000000	USD
CY2021Q4	ci	Reinsurance Recoverables Non Current ReinsuranceRecoverablesNonCurrent	4970000000	USD
CY2020Q4	ci	Reinsurance Recoverables Non Current ReinsuranceRecoverablesNonCurrent	5200000000	USD
CY2021Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	677000000	USD
CY2020Q4	us-gaap	Deferred Policy Acquisition Costs DeferredPolicyAcquisitionCosts	3385000000	USD
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	3692000000	USD
CY2020Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	4205000000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	45811000000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	44648000000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	34102000000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	35179000000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2728000000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2687000000	USD
CY2021Q4	us-gaap	Separate Account Assets SeparateAccountAssets	8337000000	USD
CY2020Q4	us-gaap	Separate Account Assets SeparateAccountAssets	9086000000	USD
CY2021Q4	us-gaap	Assets Assets	154889000000	USD
CY2020Q4	us-gaap	Assets Assets	155451000000	USD
CY2021Q4	ci	Insurance And Contractholder Liabilities Current InsuranceAndContractholderLiabilitiesCurrent	5318000000	USD
CY2020Q4	ci	Insurance And Contractholder Liabilities Current InsuranceAndContractholderLiabilitiesCurrent	5308000000	USD
CY2021Q4	ci	Pharmacy And Service Costs Payable PharmacyAndServiceCostsPayable	15309000000	USD
CY2020Q4	ci	Pharmacy And Service Costs Payable PharmacyAndServiceCostsPayable	13347000000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6655000000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5478000000	USD
CY2021Q4	ci	Accrued Expenses And Other Liabilities AccruedExpensesAndOtherLiabilities	7322000000	USD
CY2020Q4	ci	Accrued Expenses And Other Liabilities AccruedExpensesAndOtherLiabilities	8515000000	USD
CY2021Q4	us-gaap	Debt Current DebtCurrent	2545000000	USD
CY2020Q4	us-gaap	Debt Current DebtCurrent	3374000000	USD
CY2021Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	6423000000	USD
CY2020Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	USD
CY2021Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	54000000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	43572000000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	36022000000	USD
CY2021Q4	ci	Insurance And Contractholder Liabilities Noncurrent InsuranceAndContractholderLiabilitiesNoncurrent	12563000000	USD
CY2020Q4	ci	Insurance And Contractholder Liabilities Noncurrent InsuranceAndContractholderLiabilitiesNoncurrent	16844000000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	8346000000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	8939000000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3762000000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4629000000	USD
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	31125000000	USD
CY2020Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	29545000000	USD
CY2021Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	8337000000	USD
CY2020Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	9086000000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	107705000000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	105065000000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	58000000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	4000000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	4000000	USD
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	29574000000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	28975000000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-884000000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-861000000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	32593000000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	28575000000	USD
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	14175000000	USD
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	6372000000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	47112000000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	50321000000	USD
CY2021Q4	us-gaap	Minority Interest MinorityInterest	18000000	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	7000000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	47130000000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	50328000000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	154889000000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	155451000000	USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	394000000	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	390000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	41035000000	USD
CY2018Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	37000000	USD
CY2019	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	451000000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	770000000	USD
CY2019	ci	Temporary Equity Other Comprehensive Income TemporaryEquityOtherComprehensiveIncome	-5000000	USD
CY2019	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	5109000000	USD
CY2019	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	11000000	USD
CY2019	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.04
CY2019	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	15000000	USD
CY2019	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	1985000000	USD
CY2019	ci	Noncontrolling Interest Other Changes NoncontrollingInterestOtherChanges	-6000000	USD
CY2019	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	-8000000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	45344000000	USD
CY2019Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	35000000	USD
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	582000000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	80000000	USD
CY2020	ci	Temporary Equity Other Comprehensive Income TemporaryEquityOtherComprehensiveIncome	-8000000	USD
CY2020	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	8475000000	USD
CY2020	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	14000000	USD
CY2020	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.04
CY2020	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	15000000	USD
CY2020	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	4089000000	USD
CY2020	ci	Noncontrolling Interest Other Changes NoncontrollingInterestOtherChanges	-19000000	USD
CY2020	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	17000000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	50328000000	USD
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	58000000	USD
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	511000000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-23000000	USD
CY2021	ci	Temporary Equity Other Comprehensive Income TemporaryEquityOtherComprehensiveIncome	-14000000	USD
CY2021	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	5396000000	USD
CY2021	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	19000000	USD
CY2021	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	4.00
CY2021	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	1347000000	USD
CY2021	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	7710000000	USD
CY2021	ci	Noncontrolling Interest Other Changes NoncontrollingInterestOtherChanges	-25000000	USD
CY2021	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	-9000000	USD
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	47130000000	USD
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	54000000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	5415000000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	8489000000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	5120000000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2923000000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2802000000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3651000000	USD
CY2021	ci	Realized Investment Gain Loss RealizedInvestmentGainLoss	196000000	USD
CY2020	ci	Realized Investment Gain Loss RealizedInvestmentGainLoss	149000000	USD
CY2019	ci	Realized Investment Gain Loss RealizedInvestmentGainLoss	177000000	USD
CY2021	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	220000000	USD
CY2020	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	386000000	USD
CY2019	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	313000000	USD
CY2021	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	USD
CY2020	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	4203000000	USD
CY2019	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-141000000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-199000000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2000000	USD
CY2021	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	2843000000	USD
CY2020	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	1496000000	USD
CY2019	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	713000000	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	557000000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	504000000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-149000000	USD
CY2021	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	267000000	USD
CY2020	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	307000000	USD
CY2019	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	242000000	USD
CY2021	us-gaap	Increase Decrease In Reinsurance Recoverable IncreaseDecreaseInReinsuranceRecoverable	389000000	USD
CY2020	us-gaap	Increase Decrease In Reinsurance Recoverable IncreaseDecreaseInReinsuranceRecoverable	-230000000	USD
CY2019	us-gaap	Increase Decrease In Reinsurance Recoverable IncreaseDecreaseInReinsuranceRecoverable	277000000	USD
CY2021	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	967000000	USD
CY2020	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	841000000	USD
CY2019	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	575000000	USD
CY2021	ci	Increase Decrease In Pharmacy And Service Costs Payable IncreaseDecreaseInPharmacyAndServiceCostsPayable	1961000000	USD
CY2020	ci	Increase Decrease In Pharmacy And Service Costs Payable IncreaseDecreaseInPharmacyAndServiceCostsPayable	2891000000	USD
CY2019	ci	Increase Decrease In Pharmacy And Service Costs Payable IncreaseDecreaseInPharmacyAndServiceCostsPayable	-192000000	USD
CY2021	ci	Increase Decrease In Accounts Payable Accrued And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities	-77000000	USD
CY2020	ci	Increase Decrease In Accounts Payable Accrued And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities	1346000000	USD
CY2019	ci	Increase Decrease In Accounts Payable Accrued And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities	1343000000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-333000000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-597000000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-559000000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7191000000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	10350000000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	9485000000	USD
CY2021	ci	Proceeds From Sale Of Debt And Equity Securities ProceedsFromSaleOfDebtAndEquitySecurities	2030000000	USD
CY2020	ci	Proceeds From Sale Of Debt And Equity Securities ProceedsFromSaleOfDebtAndEquitySecurities	2283000000	USD
CY2019	ci	Proceeds From Sale Of Debt And Equity Securities ProceedsFromSaleOfDebtAndEquitySecurities	3487000000	USD
CY2021	ci	Proceeds From Maturities Prepayments And Calls Of Debt And Equity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities	1628000000	USD
CY2020	ci	Proceeds From Maturities Prepayments And Calls Of Debt And Equity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities	1519000000	USD
CY2019	ci	Proceeds From Maturities Prepayments And Calls Of Debt And Equity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities	1825000000	USD
CY2021	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	180000000	USD
CY2020	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	19000000	USD
CY2019	us-gaap	Proceeds From Collection Of Loans Receivable ProceedsFromCollectionOfLoansReceivable	199000000	USD
CY2021	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	1936000000	USD
CY2020	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	1575000000	USD
CY2019	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	1311000000	USD
CY2021	ci	Payments To Acquire Debt And Equity Securities PaymentsToAcquireDebtAndEquitySecurities	3553000000	USD
CY2020	ci	Payments To Acquire Debt And Equity Securities PaymentsToAcquireDebtAndEquitySecurities	4765000000	USD
CY2019	ci	Payments To Acquire Debt And Equity Securities PaymentsToAcquireDebtAndEquitySecurities	4282000000	USD
CY2021	us-gaap	Payments To Acquire Mortgage Notes Receivable PaymentsToAcquireMortgageNotesReceivable	327000000	USD
CY2020	us-gaap	Payments To Acquire Mortgage Notes Receivable PaymentsToAcquireMortgageNotesReceivable	113000000	USD
CY2019	us-gaap	Payments To Acquire Mortgage Notes Receivable PaymentsToAcquireMortgageNotesReceivable	307000000	USD
CY2021	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	2554000000	USD
CY2020	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	1924000000	USD
CY2019	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	1753000000	USD
CY2021	ci	Payments For Proceeds From Property Plant And Equipment PaymentsForProceedsFromPropertyPlantAndEquipment	1154000000	USD
CY2020	ci	Payments For Proceeds From Property Plant And Equipment PaymentsForProceedsFromPropertyPlantAndEquipment	1094000000	USD
CY2019	ci	Payments For Proceeds From Property Plant And Equipment PaymentsForProceedsFromPropertyPlantAndEquipment	1050000000	USD
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1833000000	USD
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	139000000	USD
CY2019	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	153000000	USD
CY2021	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	-61000000	USD
CY2020	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	5592000000	USD
CY2019	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	0	USD
CY2021	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-97000000	USD
CY2020	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-23000000	USD
CY2019	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	11000000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3611000000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2976000000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-734000000	USD
CY2021	us-gaap	Additions To Contract Holders Funds AdditionsToContractHoldersFunds	153000000	USD
CY2020	us-gaap	Additions To Contract Holders Funds AdditionsToContractHoldersFunds	1023000000	USD
CY2019	us-gaap	Additions To Contract Holders Funds AdditionsToContractHoldersFunds	955000000	USD
CY2021	us-gaap	Withdrawal From Contract Holders Funds WithdrawalFromContractHoldersFunds	168000000	USD
CY2020	us-gaap	Withdrawal From Contract Holders Funds WithdrawalFromContractHoldersFunds	979000000	USD
CY2019	us-gaap	Withdrawal From Contract Holders Funds WithdrawalFromContractHoldersFunds	1097000000	USD
CY2021	ci	Proceeds From Repayments Of Other Short Term Debt ProceedsFromRepaymentsOfOtherShortTermDebt	975000000	USD
CY2020	ci	Proceeds From Repayments Of Other Short Term Debt ProceedsFromRepaymentsOfOtherShortTermDebt	60000000	USD
CY2019	ci	Proceeds From Repayments Of Other Short Term Debt ProceedsFromRepaymentsOfOtherShortTermDebt	-681000000	USD
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
CY2020	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1398000000	USD
CY2019	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
CY2020	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1400000000	USD
CY2019	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	USD
CY2021	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	136000000	USD
CY2020	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	212000000	USD
CY2021	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	39000000	USD
CY2019	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	3000000	USD
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	4578000000	USD
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	8047000000	USD
CY2019	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	4491000000	USD
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	4260000000	USD
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	3465000000	USD
CY2019	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	7742000000	USD
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	4042000000	USD
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1987000000	USD
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	326000000	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	376000000	USD
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	224000000	USD
CY2021	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1341000000	USD
CY2020	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	15000000	USD
CY2019	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	15000000	USD
CY2020	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-160000000	USD
CY2019	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-92000000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-8212000000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-8533000000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-7187000000	USD
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-65000000	USD
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	41000000	USD
CY2019	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-8000000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4697000000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4834000000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1556000000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10245000000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5411000000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3855000000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5548000000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10245000000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5411000000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	425000000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	0	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	743000000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5123000000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10245000000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4668000000	USD
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2240000000	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1837000000	USD
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1776000000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	1253000000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	1439000000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	1645000000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	743000000	USD
CY2021	us-gaap	Nature Of Operations NatureOfOperations	Description of Business<div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cigna Corporation, together with its subsidiaries (either individually or collectively referred to as "Cigna," the "Company," "we," "our" or "us") is a global health services organization with a mission of helping those we serve improve their health, well-being and peace of mind by making health care affordable, predictable and simple. Our subsidiaries offer a differentiated set of pharmacy, medical, behavioral, dental and supplemental products and services. </span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of these products are offered through employers and other groups such as governmental and non-governmental organizations, unions and associations. Cigna also offers commercial health and dental insurance and Medicare products to individuals in the United States and selected international markets. In addition to these ongoing operations, Cigna also has certain run-off operations.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Details of the Company's reporting segments and recent changes are provided below:</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We entered into a definitive agreement in October 2021 to sell our life, accident and supplemental benefits businesses in seven countries to Chubb INA Holdings, Inc. ("Chubb") for $5.75 billion cash (the "Chubb Transaction"). See Note 5 for further information on the classification of these businesses as held for sale. In connection with the pending Chubb Transaction, we revised our business reporting structure. As such, we adjusted our segment reporting effective in the fourth quarter of 2021 so that the results previously reported in the International Markets segment are now reported as follows:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">The businesses to be retained by Cigna are now reported in the newly created International Health operating segment that will be aggregated with our existing U.S. Commercial and U.S. Government operating segments in the renamed Cigna Healthcare reporting segment (previously named U.S. Medical segment).</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The businesses to be sold pursuant to the Chubb Transaction are now reported in Other Operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Segment results for the years ended December 31, 2020 and 2019 have been restated to conform to the new segment presentation (see Note 23). A full description of our segments follows:</span></div><div><span><br/></span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evernorth</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> includes a broad range of coordinated and point solution health services and capabilities, as well as those from partners across the health care system, in pharmacy solutions, benefits management solutions, care delivery and care management solutions and intelligence solutions, which are provided to health plans, employers, government organizations and health care providers.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cigna Healthcare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> includes U.S. Commercial, U.S. Government and International Health operating segments that provide comprehensive medical and coordinated solutions to clients and customers. U.S. Commercial products and services include medical, pharmacy, behavioral health, dental, vision, health advocacy programs and other products and services for insured and self-insured customers. U.S. Government solutions include Medicare Advantage, Medicare Supplement and Medicare Part D plans for seniors and individual health insurance plans both on and off the public exchanges. International Health solutions include health care coverage in our international markets, as well as health care benefits for globally mobile individuals and employees of multinational organizations. The Cigna Healthcare segment is comprised of the previously named U.S. Medical segment and the businesses to be retained from the previous International Markets segment.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Other Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> contains the remainder of our business operations, consisting of the following:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Ongoing business:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Corporate-Owned Life Insurance ("COLI")</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for the purpose of financing employer-paid future benefit obligations.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Exiting businesses:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">International Life, Accident and Supplemental Benefits Businesses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in seven countries to be sold pursuant to the Chubb Transaction. </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Group Disability and Life</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Prior to the sale of the U.S. Group Disability and Life business on December 31, 2020, this operating segment provided group long-term and short-term disability, group life, accident, voluntary and specialty insurance products and related services. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Run-off businesses:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Reinsurance:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> predominantly comprised of guaranteed minimum death benefit ("GMDB") and guaranteed minimum income benefit ("GMIB") business effectively exited through reinsurance with Berkshire Hathaway Life Insurance Company of Nebraska ("Berkshire") in 2013.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Settlement Annuity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> business in run-off.</span></div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Individual Life Insurance and Annuity and Retirement Benefits businesses:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> deferred gains from the sales of these businesses.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other Operations was previously named Group Disability and Other.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reflects amounts not allocated to operating segments, including net interest expense (defined as interest on corporate debt less net investment income on investments not supporting segment and other operations), certain litigation matters, expense associated with our frozen pension plans, charitable contributions, severance, certain overhead and enterprise-wide project costs and intersegment eliminations for products and services sold between segments.</span></div>
CY2021	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	478000000	USD
CY2020	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	502000000	USD
CY2019	us-gaap	Deferred Policy Acquisition Cost Amortization Expense DeferredPolicyAcquisitionCostAmortizationExpense	483000000	USD
CY2021Q4	ci	Noninsurance Customer Receivables Excluding Pharmaceutical Manufacturers Receivable Before Reclassification To Disposal Group Assets Held For Sale NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale	6274000000	USD
CY2020Q4	ci	Noninsurance Customer Receivables Excluding Pharmaceutical Manufacturers Receivable NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivable	5534000000	USD
CY2021Q4	ci	Pharmaceutical Manufacturers Receivable Before Reclassification To Disposal Group Assets Held For Sale PharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale	5463000000	USD
CY2020Q4	ci	Pharmaceutical Manufacturer Receivable PharmaceuticalManufacturerReceivable	4676000000	USD
CY2021Q4	ci	Insurance Customer Receivables Before Reclassification To Disposal Group Assets Held For Sale InsuranceCustomerReceivablesBeforeReclassificationToDisposalGroupAssetsHeldForSale	2932000000	USD
CY2020Q4	ci	Insurance Customer Receivables InsuranceCustomerReceivables	1789000000	USD
CY2021Q4	ci	Accounts And Other Receivables Net Current Before Reclassification To Disposal Group Assets Held For Sale AccountsAndOtherReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale	456000000	USD
CY2020Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	192000000	USD
CY2021Q4	ci	Receivables Net Current Before Reclassification To Disposal Group Assets Held For Sale ReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale	15125000000	USD
CY2021Q4	us-gaap	Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet	54000000	USD
CY2021Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	15071000000	USD
CY2020Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	12191000000	USD
CY2021Q4	ci	Allowance For Receivables Net Current AllowanceForReceivablesNetCurrent	1400000000	USD
CY2020Q4	ci	Allowance For Receivables Net Current AllowanceForReceivablesNetCurrent	1200000000	USD
CY2021Q4	ci	Allowance For Credit Loss Pharmaceutical Manufacturers Receivable AllowanceForCreditLossPharmaceuticalManufacturersReceivable	926000000	USD
CY2020Q4	ci	Allowance For Credit Loss Pharmaceutical Manufacturers Receivable AllowanceForCreditLossPharmaceuticalManufacturersReceivable	757000000	USD
CY2021Q4	ci	Allowance For Credit Loss Noninsurance Customer Receivables AllowanceForCreditLossNoninsuranceCustomerReceivables	321000000	USD
CY2020Q4	ci	Allowance For Credit Loss Noninsurance Customer Receivables AllowanceForCreditLossNoninsuranceCustomerReceivables	208000000	USD
CY2021Q4	ci	Allowance For Receivables Client Credits AllowanceForReceivablesClientCredits	186000000	USD
CY2020Q4	ci	Allowance For Receivables Client Credits AllowanceForReceivablesClientCredits	224000000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	60000000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	65000000	USD
CY2021	ci	Transaction Related Costs TransactionRelatedCosts	169000000	USD
CY2021	ci	Transaction Related Costs After Tax TransactionRelatedCostsAfterTax	71000000	USD
CY2020	ci	Transaction Related Costs TransactionRelatedCosts	527000000	USD
CY2020	ci	Transaction Related Costs After Tax TransactionRelatedCostsAfterTax	404000000	USD
CY2019	ci	Transaction Related Costs TransactionRelatedCosts	552000000	USD
CY2019	ci	Transaction Related Costs After Tax TransactionRelatedCostsAfterTax	427000000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	5365000000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	5365000000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	8458000000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	8458000000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	5104000000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	5104000000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	337962000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	337962000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	364979000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	364979000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	375919000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	375919000	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3004000	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3004000	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3410000	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3410000	shares
CY2019	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3898000	shares
CY2019	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3898000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	337962000	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3004000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	340966000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	364979000	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3410000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	368389000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	375919000	shares
CY2019	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3898000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	379817000	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	15.87
CY2021	ci	Earnings Per Share Effect Of Dilution EarningsPerShareEffectOfDilution	-0.14
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	15.73

CY2021

dei

Document Fiscal Period Focus

DocumentFiscalPeriodFocus

FY

CY2021

dei

Document Fiscal Year Focus

DocumentFiscalYearFocus

2021

CY2021

dei

Amendment Flag

AmendmentFlag

false

CY2021

dei

Entity Central Index Key

EntityCentralIndexKey

0001739940

CY2021

dei

Entity File Number

EntityFileNumber

001-38769

CY2019

us-gaap

Accounting Standards Update Extensible List

AccountingStandardsUpdateExtensibleList

http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201712Member

CY2020

us-gaap

Accounting Standards Update Extensible List

AccountingStandardsUpdateExtensibleList

http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201602Member

CY2021Q4

us-gaap

Derivative Collateral Right To Reclaim Securities

DerivativeCollateralRightToReclaimSecurities

USD

CY2020Q4

us-gaap

Derivative Collateral Right To Reclaim Securities

DerivativeCollateralRightToReclaimSecurities

USD

CY2021

us-gaap

Derivative Gain Loss On Derivative Net

DerivativeGainLossOnDerivativeNet

USD

CY2020

us-gaap

Derivative Gain Loss On Derivative Net

DerivativeGainLossOnDerivativeNet

USD

CY2021

us-gaap

Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax

OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax

USD

CY2020

us-gaap

Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax

OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax

USD

CY2021

us-gaap

Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax

OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax

USD

CY2020

us-gaap

Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax

OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax

USD

CY2021

us-gaap

Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount

EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount

USD

us-gaap

Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount

EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount

USD

CY2021

us-gaap

Gain Loss From Components Excluded From Assessment Of Cash Flow Hedge Effectiveness Net

GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet

USD

CY2020

us-gaap

Gain Loss From Components Excluded From Assessment Of Cash Flow Hedge Effectiveness Net

GainLossFromComponentsExcludedFromAssessmentOfCashFlowHedgeEffectivenessNet

USD

CY2021

us-gaap

Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount

EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount

USD

CY2020

us-gaap

Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount

EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount

USD

CY2021

us-gaap

Impairment Of Intangible Assets Excluding Goodwill

ImpairmentOfIntangibleAssetsExcludingGoodwill

USD

CY2020

us-gaap

Impairment Of Intangible Assets Excluding Goodwill

ImpairmentOfIntangibleAssetsExcludingGoodwill

USD

CY2019

us-gaap

Impairment Of Intangible Assets Excluding Goodwill

ImpairmentOfIntangibleAssetsExcludingGoodwill

USD

CY2021Q4

us-gaap

Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List

OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList

http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent

CY2020Q4

us-gaap

Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List

OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList

http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent

CY2021Q4

us-gaap

Operating Lease Liability Current Statement Of Financial Position Extensible List

OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList

http://www.cigna.com/20211231#AccruedExpensesAndOtherLiabilities

CY2020Q4

us-gaap

Operating Lease Liability Current Statement Of Financial Position Extensible List

OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList

http://www.cigna.com/20211231#AccruedExpensesAndOtherLiabilities

CY2021Q4

us-gaap

Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List

OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList

http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent

CY2020Q4

us-gaap

Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List

OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList

http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent

CY2021Q4

us-gaap

Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List

FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList

http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization

CY2020Q4

us-gaap

Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List

FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList

http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization

CY2021Q4

us-gaap

Finance Lease Liability Current Statement Of Financial Position Extensible List

FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList

http://fasb.org/us-gaap/2021-01-31#DebtCurrent

CY2020Q4

us-gaap

Finance Lease Liability Current Statement Of Financial Position Extensible List

FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList

http://fasb.org/us-gaap/2021-01-31#DebtCurrent

CY2021Q4

us-gaap

Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List

FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList

http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligations

CY2020Q4

us-gaap

Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List

FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList

http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligations

CY2021Q4

us-gaap

Operating Lease Liability Current Statement Of Financial Position Extensible List

OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList

http://www.cigna.com/20211231#AccruedExpensesAndOtherLiabilities

CY2020Q4

us-gaap

Operating Lease Liability Current Statement Of Financial Position Extensible List

OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList

http://www.cigna.com/20211231#AccruedExpensesAndOtherLiabilities

CY2021Q4

us-gaap

Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List

OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList

http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent

CY2020Q4

us-gaap

Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List

OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList

http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent

CY2021Q4

us-gaap

Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List

FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList

http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization

CY2020Q4

us-gaap

Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List

FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList

http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization

CY2020Q4

us-gaap

Finance Lease Liability Current Statement Of Financial Position Extensible List

FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList

http://fasb.org/us-gaap/2021-01-31#DebtCurrent

CY2021Q4

us-gaap

Finance Lease Liability Current Statement Of Financial Position Extensible List

FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList

http://fasb.org/us-gaap/2021-01-31#DebtCurrent

CY2021Q4

us-gaap

Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List

FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList

http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligations

CY2020Q4

us-gaap

Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List

FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList

http://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligations

CY2021

dei

Document Type

DocumentType

10-K

CY2021

dei

Document Annual Report

DocumentAnnualReport

true

CY2021

dei

Document Period End Date

DocumentPeriodEndDate

2021-12-31

CY2021

dei

Current Fiscal Year End Date

CurrentFiscalYearEndDate

--12-31

CY2021

dei

Document Transition Report

DocumentTransitionReport

false

CY2021

dei

Entity Registrant Name

EntityRegistrantName

Cigna Corporation

CY2021

dei

Entity Incorporation State Country Code

EntityIncorporationStateCountryCode

DE

CY2021

dei

Entity Tax Identification Number

EntityTaxIdentificationNumber

82-4991898

CY2021

dei

Entity Address Address Line1

EntityAddressAddressLine1

900 Cottage Grove Road

CY2021

dei

Entity Address City Or Town

EntityAddressCityOrTown

Bloomfield

CY2021

dei

Entity Address State Or Province

EntityAddressStateOrProvince

CT

CY2021

dei

Entity Address Postal Zip Code

EntityAddressPostalZipCode

06002

CY2021

dei

City Area Code

CityAreaCode

860

CY2021

dei

Local Phone Number

LocalPhoneNumber

226-6000

CY2021

dei

Security12b Title

Security12bTitle

Common Stock, Par Value $0.01

CY2021

dei

Trading Symbol

TradingSymbol

CI

CY2021

dei

Security Exchange Name

SecurityExchangeName

NYSE

CY2021

dei

Entity Well Known Seasoned Issuer

EntityWellKnownSeasonedIssuer

Yes

CY2021

dei

Entity Current Reporting Status

EntityCurrentReportingStatus

Yes

CY2021

dei

Entity Interactive Data Current

EntityInteractiveDataCurrent

Yes

CY2021

dei

Entity Voluntary Filers

EntityVoluntaryFilers

No

CY2021

dei

Entity Filer Category

EntityFilerCategory

Large Accelerated Filer

CY2021

dei

Entity Small Business

EntitySmallBusiness

false

CY2021

dei

Entity Emerging Growth Company

EntityEmergingGrowthCompany

false

CY2021

dei

Icfr Auditor Attestation Flag

IcfrAuditorAttestationFlag

true

CY2021

dei

Entity Shell Company

EntityShellCompany

false

CY2021Q2

dei

Entity Public Float

EntityPublicFloat

80800000000

USD

CY2022Q1

dei

Entity Common Stock Shares Outstanding

EntityCommonStockSharesOutstanding

320953245

shares

CY2021

dei

Auditor Name

AuditorName

PricewaterhouseCoopers LLP

CY2021

dei

Auditor Location

AuditorLocation

Hartford, Connecticut

CY2021

us-gaap

Premiums Earned Net

PremiumsEarnedNet

41154000000

USD

CY2020

us-gaap

Premiums Earned Net

PremiumsEarnedNet

42627000000

USD

CY2019

us-gaap

Premiums Earned Net

PremiumsEarnedNet

39714000000

USD

CY2021

us-gaap

Net Investment Income

NetInvestmentIncome

1549000000

USD

CY2020

us-gaap

Net Investment Income

NetInvestmentIncome

1244000000

USD

CY2019

us-gaap

Net Investment Income

NetInvestmentIncome

1390000000

USD

CY2021

us-gaap

Revenues

174078000000

USD

CY2020

us-gaap

Revenues

160401000000

USD

CY2019

us-gaap

Revenues

153566000000

USD

CY2021

us-gaap

Cost Of Goods And Services Sold

CostOfGoodsAndServicesSold

117553000000

USD

CY2020

us-gaap

Cost Of Goods And Services Sold

CostOfGoodsAndServicesSold

103484000000

USD

CY2019

us-gaap

Cost Of Goods And Services Sold

CostOfGoodsAndServicesSold

97668000000

USD

CY2021

us-gaap

Policyholder Benefits And Claims Incurred Net

PolicyholderBenefitsAndClaimsIncurredNet

33562000000

USD

CY2020

us-gaap

Policyholder Benefits And Claims Incurred Net

PolicyholderBenefitsAndClaimsIncurredNet

32710000000

USD

CY2019

us-gaap

Policyholder Benefits And Claims Incurred Net

PolicyholderBenefitsAndClaimsIncurredNet

30819000000

USD

CY2021

us-gaap

Selling General And Administrative Expense

SellingGeneralAndAdministrativeExpense

13030000000

USD

CY2020

us-gaap

Selling General And Administrative Expense

SellingGeneralAndAdministrativeExpense

14072000000

USD

CY2019

us-gaap

Selling General And Administrative Expense

SellingGeneralAndAdministrativeExpense

14053000000

USD

CY2021

us-gaap

Amortization Of Intangible Assets

AmortizationOfIntangibleAssets

1998000000

USD

CY2020

us-gaap

Amortization Of Intangible Assets

AmortizationOfIntangibleAssets

1982000000

USD

CY2019

us-gaap

Amortization Of Intangible Assets

AmortizationOfIntangibleAssets

2949000000

USD

CY2021

us-gaap

Benefits Losses And Expenses

BenefitsLossesAndExpenses

166143000000

USD

CY2020

us-gaap

Benefits Losses And Expenses

BenefitsLossesAndExpenses

152248000000

USD

CY2019

us-gaap

Benefits Losses And Expenses

BenefitsLossesAndExpenses

145489000000

USD

CY2021

us-gaap

Operating Income Loss

OperatingIncomeLoss

7935000000

USD

CY2020

us-gaap

Operating Income Loss

OperatingIncomeLoss

8153000000

USD

CY2019

us-gaap

Operating Income Loss

OperatingIncomeLoss

8077000000

USD

CY2021

us-gaap

Other Nonoperating Income Expense

OtherNonoperatingIncomeExpense

-1208000000

USD

CY2020

us-gaap

Other Nonoperating Income Expense

OtherNonoperatingIncomeExpense

-1438000000

USD

CY2019

us-gaap

Other Nonoperating Income Expense

OtherNonoperatingIncomeExpense

-1682000000

USD

CY2021

us-gaap

Gains Losses On Extinguishment Of Debt

GainsLossesOnExtinguishmentOfDebt

-141000000

USD

CY2020

us-gaap

Gains Losses On Extinguishment Of Debt

GainsLossesOnExtinguishmentOfDebt

-199000000

USD

CY2019

us-gaap

Gains Losses On Extinguishment Of Debt

GainsLossesOnExtinguishmentOfDebt

-2000000

USD

CY2021

us-gaap

Gain Loss On Sale Of Business

GainLossOnSaleOfBusiness

0

USD

CY2020

us-gaap

Gain Loss On Sale Of Business

GainLossOnSaleOfBusiness

4203000000

USD

CY2019

us-gaap

Gain Loss On Sale Of Business

GainLossOnSaleOfBusiness

0

USD

CY2021

ci

Realized Investment Gain Loss

RealizedInvestmentGainLoss

196000000

USD

CY2020

ci

Realized Investment Gain Loss

RealizedInvestmentGainLoss

149000000

USD

CY2019

ci

Realized Investment Gain Loss

RealizedInvestmentGainLoss

177000000

USD

CY2021

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

6782000000

USD

CY2020

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

10868000000

USD

CY2019

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

6570000000

USD

CY2021

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

1367000000

USD

CY2020

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

2379000000

USD

CY2019

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

1450000000

USD

CY2021

us-gaap

Profit Loss

ProfitLoss

5415000000

USD

CY2020

us-gaap

Profit Loss

ProfitLoss

8489000000

USD

CY2019

us-gaap

Profit Loss

ProfitLoss

5120000000

USD

CY2021

us-gaap

Net Income Loss Attributable To Noncontrolling Interest

NetIncomeLossAttributableToNoncontrollingInterest

50000000

USD

CY2020

us-gaap

Net Income Loss Attributable To Noncontrolling Interest

NetIncomeLossAttributableToNoncontrollingInterest

31000000

USD

CY2019

us-gaap

Net Income Loss Attributable To Noncontrolling Interest

NetIncomeLossAttributableToNoncontrollingInterest

16000000

USD

CY2021

us-gaap

Net Income Loss Available To Common Stockholders Basic

NetIncomeLossAvailableToCommonStockholdersBasic

5365000000

USD

CY2020

us-gaap

Net Income Loss Available To Common Stockholders Basic

NetIncomeLossAvailableToCommonStockholdersBasic

8458000000

USD

CY2019

us-gaap

Net Income Loss Available To Common Stockholders Basic

NetIncomeLossAvailableToCommonStockholdersBasic

5104000000

USD

CY2021

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

15.87

CY2020

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

23.17

CY2019

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

13.58

CY2021

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

15.73

CY2020

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

22.96

CY2019

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

13.44

CY2021

us-gaap

Profit Loss

ProfitLoss

5415000000

USD

CY2020

us-gaap

Profit Loss

ProfitLoss

8489000000

USD

CY2021

us-gaap

Net Income Loss Attributable To Redeemable Noncontrolling Interest

NetIncomeLossAttributableToRedeemableNoncontrollingInterest

19000000

USD

CY2020

us-gaap

Net Income Loss Attributable To Redeemable Noncontrolling Interest

NetIncomeLossAttributableToRedeemableNoncontrollingInterest

14000000

USD

CY2019

us-gaap

Net Income Loss Attributable To Redeemable Noncontrolling Interest

NetIncomeLossAttributableToRedeemableNoncontrollingInterest

11000000

USD

CY2021

us-gaap

Net Income Loss Attributable To Nonredeemable Noncontrolling Interest

NetIncomeLossAttributableToNonredeemableNoncontrollingInterest

31000000

USD

CY2020

us-gaap

Net Income Loss Attributable To Nonredeemable Noncontrolling Interest

NetIncomeLossAttributableToNonredeemableNoncontrollingInterest

17000000

USD

CY2019

us-gaap

Net Income Loss Attributable To Nonredeemable Noncontrolling Interest

NetIncomeLossAttributableToNonredeemableNoncontrollingInterest

5000000

USD

CY2021

ci

Temporary Equity Other Comprehensive Income

TemporaryEquityOtherComprehensiveIncome

-14000000

USD

CY2020

ci

Temporary Equity Other Comprehensive Income

TemporaryEquityOtherComprehensiveIncome

-8000000

USD

CY2019

ci

Temporary Equity Other Comprehensive Income

TemporaryEquityOtherComprehensiveIncome

-5000000

USD

CY2021

us-gaap

Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest

ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest

36000000

USD

CY2020

us-gaap

Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest

ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest

23000000

USD

CY2019

us-gaap

Profit Loss

ProfitLoss

5120000000

USD

CY2021

ci

Other Comprehensive Income Loss Available For Sale Securities And Derivatives Adjustment Net Of Tax

OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax

-215000000

USD

CY2020

ci

Other Comprehensive Income Loss Available For Sale Securities And Derivatives Adjustment Net Of Tax

OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax

-75000000

USD

CY2019

ci

Other Comprehensive Income Loss Available For Sale Securities And Derivatives Adjustment Net Of Tax

OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAndDerivativesAdjustmentNetOfTax

957000000

USD

CY2021

ci

Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax Including Temporary Equity

OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity

-232000000

USD

CY2020

ci

Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax Including Temporary Equity

OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity

252000000

USD

CY2019

ci

Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax Including Temporary Equity

OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxIncludingTemporaryEquity

-59000000

USD

CY2021

us-gaap

Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax

OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax

-410000000

USD

CY2020

us-gaap

Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax

OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax

105000000

USD

CY2019

us-gaap

Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax

OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax

133000000

USD

CY2021

ci

Other Comprehensive Income Loss Net Of Tax Including Temporary Equity

OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity

-37000000

USD

CY2020

ci

Other Comprehensive Income Loss Net Of Tax Including Temporary Equity

OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity

72000000

USD

CY2019

ci

Other Comprehensive Income Loss Net Of Tax Including Temporary Equity

OtherComprehensiveIncomeLossNetOfTaxIncludingTemporaryEquity

765000000

USD

CY2021

ci

Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest Including Temporary Equity

ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity

5378000000

USD

CY2020

ci

Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest Including Temporary Equity

ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity

8561000000

USD

CY2019

ci

Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest Including Temporary Equity

ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestIncludingTemporaryEquity

5885000000

USD

CY2019

us-gaap

Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest

ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest

11000000

USD

CY2021

us-gaap

Comprehensive Income Net Of Tax

ComprehensiveIncomeNetOfTax

5342000000

USD

CY2020

us-gaap

Comprehensive Income Net Of Tax

ComprehensiveIncomeNetOfTax

8538000000

USD

CY2019

us-gaap

Comprehensive Income Net Of Tax

ComprehensiveIncomeNetOfTax

5874000000

USD

CY2021Q4

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

5081000000

USD

CY2020Q4

us-gaap

Cash And Cash Equivalents At Carrying Value

CashAndCashEquivalentsAtCarryingValue

10182000000

USD

CY2021Q4

us-gaap

Short Term Investments

ShortTermInvestments

920000000

USD

CY2020Q4

us-gaap

Short Term Investments

ShortTermInvestments

1331000000

USD

CY2021Q4

us-gaap

Receivables Net Current

ReceivablesNetCurrent

15071000000

USD

CY2020Q4

us-gaap

Receivables Net Current

ReceivablesNetCurrent

12191000000

USD

CY2021Q4

us-gaap

Inventory Net

InventoryNet

3722000000

USD

CY2020Q4

us-gaap

Inventory Net

InventoryNet

3165000000

USD

CY2021Q4

us-gaap

Other Assets Current

OtherAssetsCurrent

1283000000

USD

CY2020Q4

us-gaap

Other Assets Current

OtherAssetsCurrent

930000000

USD

CY2021Q4

us-gaap

Assets Of Disposal Group Including Discontinued Operation Current

AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent

10057000000

USD

CY2020Q4

us-gaap

Assets Of Disposal Group Including Discontinued Operation Current

AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent

0

USD

CY2021Q4

us-gaap

Assets Current

AssetsCurrent

36134000000

USD

CY2020Q4

us-gaap

Assets Current

AssetsCurrent

27799000000

USD

CY2021Q4

us-gaap

Long Term Investments

LongTermInvestments

18438000000

USD

CY2020Q4

us-gaap

Long Term Investments

LongTermInvestments

23262000000

USD

CY2021Q4

ci

Reinsurance Recoverables Non Current

ReinsuranceRecoverablesNonCurrent

4970000000

USD

CY2020Q4

ci

Reinsurance Recoverables Non Current

ReinsuranceRecoverablesNonCurrent

5200000000

USD

CY2021Q4

us-gaap

Deferred Policy Acquisition Costs

DeferredPolicyAcquisitionCosts

677000000

USD

CY2020Q4

us-gaap

Deferred Policy Acquisition Costs

DeferredPolicyAcquisitionCosts

3385000000

USD

CY2021Q4

us-gaap

Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization

PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization

3692000000

USD

CY2020Q4

us-gaap

Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization

PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization

4205000000

USD

CY2021Q4

us-gaap

Goodwill

45811000000

USD

CY2020Q4

us-gaap

Goodwill

44648000000

USD

CY2021Q4

us-gaap

Intangible Assets Net Excluding Goodwill

IntangibleAssetsNetExcludingGoodwill

34102000000

USD

CY2020Q4

us-gaap

Intangible Assets Net Excluding Goodwill

IntangibleAssetsNetExcludingGoodwill

35179000000

USD

CY2021Q4

us-gaap

Other Assets Noncurrent

OtherAssetsNoncurrent

2728000000

USD

CY2020Q4

us-gaap

Other Assets Noncurrent

OtherAssetsNoncurrent

2687000000

USD

CY2021Q4

us-gaap

Separate Account Assets

SeparateAccountAssets

8337000000

USD

CY2020Q4

us-gaap

Separate Account Assets

SeparateAccountAssets

9086000000

USD

CY2021Q4

us-gaap

Assets

154889000000

USD

CY2020Q4

us-gaap

Assets

155451000000

USD

CY2021Q4

ci

Insurance And Contractholder Liabilities Current

InsuranceAndContractholderLiabilitiesCurrent

5318000000

USD

CY2020Q4

ci

Insurance And Contractholder Liabilities Current

InsuranceAndContractholderLiabilitiesCurrent

5308000000

USD

CY2021Q4

ci

Pharmacy And Service Costs Payable

PharmacyAndServiceCostsPayable

15309000000

USD

CY2020Q4

ci

Pharmacy And Service Costs Payable

PharmacyAndServiceCostsPayable

13347000000

USD

CY2021Q4

us-gaap

Accounts Payable Current

AccountsPayableCurrent

6655000000

USD

CY2020Q4

us-gaap

Accounts Payable Current

AccountsPayableCurrent

5478000000

USD

CY2021Q4

ci

Accrued Expenses And Other Liabilities

AccruedExpensesAndOtherLiabilities

7322000000

USD

CY2020Q4

ci

Accrued Expenses And Other Liabilities

AccruedExpensesAndOtherLiabilities

8515000000

USD

CY2021Q4

us-gaap

Debt Current

DebtCurrent

2545000000

USD

CY2020Q4

us-gaap

Debt Current

DebtCurrent

3374000000

USD

CY2021Q4

us-gaap

Liabilities Of Disposal Group Including Discontinued Operation Current

LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent

6423000000

USD

CY2020Q4

us-gaap

Liabilities Of Disposal Group Including Discontinued Operation Current

LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent

0

USD

CY2021Q4

us-gaap

Redeemable Noncontrolling Interest Equity Carrying Amount

RedeemableNoncontrollingInterestEquityCarryingAmount

54000000

USD

CY2021Q4

us-gaap

Liabilities Current

LiabilitiesCurrent

43572000000

USD

CY2020Q4

us-gaap

Liabilities Current

LiabilitiesCurrent

36022000000

USD

CY2021Q4

ci

Insurance And Contractholder Liabilities Noncurrent

InsuranceAndContractholderLiabilitiesNoncurrent

12563000000

USD

CY2020Q4

ci

Insurance And Contractholder Liabilities Noncurrent

InsuranceAndContractholderLiabilitiesNoncurrent

16844000000

USD

CY2021Q4

us-gaap

Deferred Income Tax Liabilities Net

DeferredIncomeTaxLiabilitiesNet

8346000000

USD

CY2020Q4

us-gaap

Deferred Income Tax Liabilities Net

DeferredIncomeTaxLiabilitiesNet

8939000000

USD

CY2021Q4

us-gaap

Other Liabilities Noncurrent

OtherLiabilitiesNoncurrent

3762000000

USD

CY2020Q4

us-gaap

Other Liabilities Noncurrent

OtherLiabilitiesNoncurrent

4629000000

USD

CY2021Q4

us-gaap

Long Term Debt And Capital Lease Obligations

LongTermDebtAndCapitalLeaseObligations

31125000000

USD

CY2020Q4

us-gaap

Long Term Debt And Capital Lease Obligations

LongTermDebtAndCapitalLeaseObligations

29545000000

USD

CY2021Q4

us-gaap

Separate Accounts Liability

SeparateAccountsLiability

8337000000

USD

CY2020Q4

us-gaap

Separate Accounts Liability

SeparateAccountsLiability

9086000000

USD

CY2021Q4

us-gaap

Liabilities

107705000000

USD

CY2020Q4

us-gaap

Liabilities

105065000000

USD

CY2021Q4

us-gaap

Commitments And Contingencies

CommitmentsAndContingencies

USD

CY2020Q4

us-gaap

Commitments And Contingencies

CommitmentsAndContingencies

USD

CY2020Q4

us-gaap

Redeemable Noncontrolling Interest Equity Carrying Amount

RedeemableNoncontrollingInterestEquityCarryingAmount

58000000

USD

CY2021Q4

us-gaap

Common Stock Value

CommonStockValue

4000000

USD

CY2020Q4

us-gaap

Common Stock Value

CommonStockValue

4000000

USD

CY2021Q4

us-gaap

Additional Paid In Capital Common Stock

AdditionalPaidInCapitalCommonStock

29574000000

USD

CY2020Q4

us-gaap

Additional Paid In Capital Common Stock

AdditionalPaidInCapitalCommonStock

28975000000

USD

CY2021Q4

us-gaap

Accumulated Other Comprehensive Income Loss Net Of Tax

AccumulatedOtherComprehensiveIncomeLossNetOfTax

-884000000

USD

CY2020Q4

us-gaap

Accumulated Other Comprehensive Income Loss Net Of Tax

AccumulatedOtherComprehensiveIncomeLossNetOfTax

-861000000

USD

CY2021Q4

us-gaap

Retained Earnings Accumulated Deficit

RetainedEarningsAccumulatedDeficit

32593000000

USD

CY2020Q4

us-gaap

Retained Earnings Accumulated Deficit

RetainedEarningsAccumulatedDeficit

28575000000

USD

CY2021Q4

us-gaap

Treasury Stock Value

TreasuryStockValue

14175000000

USD

CY2020Q4

us-gaap

Treasury Stock Value

TreasuryStockValue

6372000000

USD

CY2021Q4

us-gaap

Stockholders Equity

StockholdersEquity

47112000000

USD

CY2020Q4

us-gaap

Stockholders Equity

StockholdersEquity

50321000000

USD

CY2021Q4

us-gaap

Minority Interest

MinorityInterest

18000000

USD

CY2020Q4

us-gaap

Minority Interest

MinorityInterest

7000000

USD

CY2021Q4

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

47130000000

USD

CY2020Q4

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

50328000000

USD

CY2021Q4

us-gaap

Liabilities And Stockholders Equity

LiabilitiesAndStockholdersEquity

154889000000

USD

CY2020Q4

us-gaap

Liabilities And Stockholders Equity

LiabilitiesAndStockholdersEquity

155451000000

USD

CY2021Q4

us-gaap

Common Stock Par Or Stated Value Per Share

CommonStockParOrStatedValuePerShare

0.01

CY2020Q4

us-gaap

Common Stock Par Or Stated Value Per Share

CommonStockParOrStatedValuePerShare

0.01

CY2021Q4

us-gaap

Common Stock Shares Issued

CommonStockSharesIssued

394000000

shares

CY2020Q4

us-gaap

Common Stock Shares Issued

CommonStockSharesIssued

390000000

shares

CY2020Q4

us-gaap

Common Stock Shares Authorized

CommonStockSharesAuthorized

600000000

shares

CY2021Q4

us-gaap

Common Stock Shares Authorized

CommonStockSharesAuthorized

600000000

shares

CY2018Q4

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

41035000000

USD

CY2018Q4

us-gaap

Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests

TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests

37000000

USD

CY2019

us-gaap

Stock Issued During Period Value Share Based Compensation

StockIssuedDuringPeriodValueShareBasedCompensation

451000000

USD

CY2019

us-gaap

Other Comprehensive Income Loss Net Of Tax

OtherComprehensiveIncomeLossNetOfTax

770000000

USD

CY2019

ci

Temporary Equity Other Comprehensive Income

TemporaryEquityOtherComprehensiveIncome

-5000000

USD

CY2019

us-gaap

Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest

NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest

5109000000

USD

CY2019

us-gaap

Temporary Equity Net Income

TemporaryEquityNetIncome

11000000

USD

CY2019

us-gaap

Common Stock Dividends Per Share Declared

CommonStockDividendsPerShareDeclared

0.04

CY2019

us-gaap

Dividends Common Stock Cash

DividendsCommonStockCash

15000000

USD

CY2019

us-gaap

Treasury Stock Value Acquired Cost Method

TreasuryStockValueAcquiredCostMethod

1985000000

USD

CY2019

ci

Noncontrolling Interest Other Changes

NoncontrollingInterestOtherChanges

-6000000

USD

CY2019

us-gaap

Temporary Equity Other Changes

TemporaryEquityOtherChanges

-8000000

USD

CY2019Q4

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

45344000000

USD

CY2019Q4

us-gaap

Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests

TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests

35000000

USD

CY2020

us-gaap

Stock Issued During Period Value Share Based Compensation

StockIssuedDuringPeriodValueShareBasedCompensation

582000000

USD

CY2020

us-gaap

Other Comprehensive Income Loss Net Of Tax

OtherComprehensiveIncomeLossNetOfTax

80000000

USD

CY2020

ci

Temporary Equity Other Comprehensive Income

TemporaryEquityOtherComprehensiveIncome

-8000000

USD

CY2020

us-gaap

Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest

NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest

8475000000

USD

CY2020

us-gaap

Temporary Equity Net Income

TemporaryEquityNetIncome

14000000

USD

CY2020

us-gaap

Common Stock Dividends Per Share Declared

CommonStockDividendsPerShareDeclared

0.04

CY2020

us-gaap

Dividends Common Stock Cash

DividendsCommonStockCash

15000000

USD

CY2020

us-gaap

Treasury Stock Value Acquired Cost Method

TreasuryStockValueAcquiredCostMethod

4089000000

USD

CY2020

ci

Noncontrolling Interest Other Changes

NoncontrollingInterestOtherChanges

-19000000

USD

CY2020

us-gaap

Temporary Equity Other Changes

TemporaryEquityOtherChanges

17000000

USD

CY2020Q4

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

50328000000

USD

CY2020Q4

us-gaap

Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests

TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests

58000000

USD

CY2021

us-gaap

Stock Issued During Period Value Share Based Compensation

StockIssuedDuringPeriodValueShareBasedCompensation

511000000

USD

CY2021

us-gaap

Other Comprehensive Income Loss Net Of Tax

OtherComprehensiveIncomeLossNetOfTax

-23000000

USD

CY2021

ci

Temporary Equity Other Comprehensive Income

TemporaryEquityOtherComprehensiveIncome

-14000000

USD

CY2021

us-gaap

Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest

NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest

5396000000

USD

CY2021

us-gaap

Temporary Equity Net Income

TemporaryEquityNetIncome

19000000

USD

CY2021

us-gaap

Common Stock Dividends Per Share Declared

CommonStockDividendsPerShareDeclared

4.00

CY2021

us-gaap

Dividends Common Stock Cash

DividendsCommonStockCash

1347000000

USD

CY2021

us-gaap

Treasury Stock Value Acquired Cost Method

TreasuryStockValueAcquiredCostMethod

7710000000

USD

CY2021

ci

Noncontrolling Interest Other Changes

NoncontrollingInterestOtherChanges

-25000000

USD

CY2021

us-gaap

Temporary Equity Other Changes

TemporaryEquityOtherChanges

-9000000

USD

CY2021Q4

us-gaap

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

47130000000

USD

CY2021Q4

us-gaap

Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests

TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests

54000000

USD

CY2021

us-gaap

Profit Loss

ProfitLoss

5415000000

USD

CY2020

us-gaap

Profit Loss

ProfitLoss

8489000000

USD

CY2019

us-gaap

Profit Loss

ProfitLoss

5120000000

USD

CY2021

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

2923000000

USD

CY2020

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

2802000000

USD

CY2019

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

3651000000

USD

CY2021

ci

Realized Investment Gain Loss

RealizedInvestmentGainLoss

196000000

USD

CY2020

ci

Realized Investment Gain Loss

RealizedInvestmentGainLoss

149000000

USD

CY2019

ci

Realized Investment Gain Loss

RealizedInvestmentGainLoss

177000000

USD

CY2021

us-gaap

Increase Decrease In Deferred Income Taxes

IncreaseDecreaseInDeferredIncomeTaxes

220000000

USD

CY2020

us-gaap

Increase Decrease In Deferred Income Taxes

IncreaseDecreaseInDeferredIncomeTaxes

386000000

USD

CY2019

us-gaap

Increase Decrease In Deferred Income Taxes

IncreaseDecreaseInDeferredIncomeTaxes

313000000

USD

CY2021

us-gaap

Gain Loss On Sale Of Business

GainLossOnSaleOfBusiness

0

USD

CY2020

us-gaap

Gain Loss On Sale Of Business

GainLossOnSaleOfBusiness

4203000000

USD

CY2019

us-gaap

Gain Loss On Sale Of Business

GainLossOnSaleOfBusiness

0

USD

CY2021

us-gaap

Gains Losses On Extinguishment Of Debt

GainsLossesOnExtinguishmentOfDebt

-141000000

USD

CY2020

us-gaap

Gains Losses On Extinguishment Of Debt

GainsLossesOnExtinguishmentOfDebt

-199000000

USD

CY2019

us-gaap

Gains Losses On Extinguishment Of Debt

GainsLossesOnExtinguishmentOfDebt

-2000000

USD

CY2021

us-gaap

Increase Decrease In Accounts And Other Receivables

IncreaseDecreaseInAccountsAndOtherReceivables

2843000000

USD

CY2020

us-gaap

Increase Decrease In Accounts And Other Receivables

IncreaseDecreaseInAccountsAndOtherReceivables

1496000000

USD

CY2019

us-gaap

Increase Decrease In Accounts And Other Receivables

IncreaseDecreaseInAccountsAndOtherReceivables

713000000

USD

CY2021

us-gaap

Increase Decrease In Inventories

IncreaseDecreaseInInventories

557000000

USD

CY2020

us-gaap

Increase Decrease In Inventories

IncreaseDecreaseInInventories

504000000

USD

CY2019

us-gaap

Increase Decrease In Inventories

IncreaseDecreaseInInventories

-149000000

USD

CY2021

us-gaap

Increase Decrease In Deferred Policy Acquisition Costs

IncreaseDecreaseInDeferredPolicyAcquisitionCosts

267000000

USD

CY2020

us-gaap

Increase Decrease In Deferred Policy Acquisition Costs

IncreaseDecreaseInDeferredPolicyAcquisitionCosts

307000000

USD

CY2019

us-gaap

Increase Decrease In Deferred Policy Acquisition Costs

IncreaseDecreaseInDeferredPolicyAcquisitionCosts

242000000

USD

CY2021

us-gaap

Increase Decrease In Reinsurance Recoverable

IncreaseDecreaseInReinsuranceRecoverable

389000000

USD

CY2020

us-gaap

Increase Decrease In Reinsurance Recoverable

IncreaseDecreaseInReinsuranceRecoverable

-230000000

USD

CY2019

us-gaap

Increase Decrease In Reinsurance Recoverable

IncreaseDecreaseInReinsuranceRecoverable

277000000

USD

CY2021

us-gaap

Increase Decrease In Insurance Liabilities

IncreaseDecreaseInInsuranceLiabilities

967000000

USD

CY2020

us-gaap

Increase Decrease In Insurance Liabilities

IncreaseDecreaseInInsuranceLiabilities

841000000

USD

CY2019

us-gaap

Increase Decrease In Insurance Liabilities

IncreaseDecreaseInInsuranceLiabilities

575000000

USD

CY2021

ci

Increase Decrease In Pharmacy And Service Costs Payable

IncreaseDecreaseInPharmacyAndServiceCostsPayable

1961000000

USD

CY2020

ci

Increase Decrease In Pharmacy And Service Costs Payable

IncreaseDecreaseInPharmacyAndServiceCostsPayable

2891000000

USD

CY2019

ci

Increase Decrease In Pharmacy And Service Costs Payable

IncreaseDecreaseInPharmacyAndServiceCostsPayable

-192000000

USD

CY2021

ci

Increase Decrease In Accounts Payable Accrued And Other Operating Liabilities

IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities

-77000000

USD

CY2020

ci

Increase Decrease In Accounts Payable Accrued And Other Operating Liabilities

IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities

1346000000

USD

CY2019

ci

Increase Decrease In Accounts Payable Accrued And Other Operating Liabilities

IncreaseDecreaseInAccountsPayableAccruedAndOtherOperatingLiabilities

1343000000

USD

CY2021

us-gaap

Increase Decrease In Other Operating Capital Net

IncreaseDecreaseInOtherOperatingCapitalNet

-333000000

USD

CY2020

us-gaap

Increase Decrease In Other Operating Capital Net

IncreaseDecreaseInOtherOperatingCapitalNet

-597000000

USD

CY2019

us-gaap

Increase Decrease In Other Operating Capital Net

IncreaseDecreaseInOtherOperatingCapitalNet

-559000000

USD

CY2021

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

7191000000

USD

CY2020

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

10350000000

USD

CY2019

us-gaap

Net Cash Provided By Used In Operating Activities

NetCashProvidedByUsedInOperatingActivities

9485000000

USD

CY2021

ci

Proceeds From Sale Of Debt And Equity Securities

ProceedsFromSaleOfDebtAndEquitySecurities

2030000000

USD

CY2020

ci

Proceeds From Sale Of Debt And Equity Securities

ProceedsFromSaleOfDebtAndEquitySecurities

2283000000

USD

CY2019

ci

Proceeds From Sale Of Debt And Equity Securities

ProceedsFromSaleOfDebtAndEquitySecurities

3487000000

USD

CY2021

ci

Proceeds From Maturities Prepayments And Calls Of Debt And Equity Securities

ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities

1628000000

USD

CY2020

ci

Proceeds From Maturities Prepayments And Calls Of Debt And Equity Securities

ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities

1519000000

USD

CY2019

ci

Proceeds From Maturities Prepayments And Calls Of Debt And Equity Securities

ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtAndEquitySecurities

1825000000

USD

CY2021

us-gaap

Proceeds From Collection Of Loans Receivable

ProceedsFromCollectionOfLoansReceivable

180000000

USD

CY2020

us-gaap

Proceeds From Collection Of Loans Receivable

ProceedsFromCollectionOfLoansReceivable

19000000

USD

CY2019

us-gaap

Proceeds From Collection Of Loans Receivable

ProceedsFromCollectionOfLoansReceivable

199000000

USD

CY2021

us-gaap

Proceeds From Sale And Maturity Of Other Investments

ProceedsFromSaleAndMaturityOfOtherInvestments

1936000000

USD

CY2020

us-gaap

Proceeds From Sale And Maturity Of Other Investments

ProceedsFromSaleAndMaturityOfOtherInvestments

1575000000

USD

CY2019

us-gaap

Proceeds From Sale And Maturity Of Other Investments

ProceedsFromSaleAndMaturityOfOtherInvestments

1311000000

USD

CY2021

ci

Payments To Acquire Debt And Equity Securities

PaymentsToAcquireDebtAndEquitySecurities

3553000000

USD

CY2020

ci

Payments To Acquire Debt And Equity Securities

PaymentsToAcquireDebtAndEquitySecurities

4765000000

USD

CY2019

ci

Payments To Acquire Debt And Equity Securities

PaymentsToAcquireDebtAndEquitySecurities

4282000000

USD

CY2021

us-gaap

Payments To Acquire Mortgage Notes Receivable

PaymentsToAcquireMortgageNotesReceivable

327000000

USD

CY2020

us-gaap

Payments To Acquire Mortgage Notes Receivable

PaymentsToAcquireMortgageNotesReceivable

113000000

USD

CY2019

us-gaap

Payments To Acquire Mortgage Notes Receivable

PaymentsToAcquireMortgageNotesReceivable

307000000

USD

CY2021

us-gaap

Payments To Acquire Other Investments

PaymentsToAcquireOtherInvestments

2554000000

USD

CY2020

us-gaap

Payments To Acquire Other Investments

PaymentsToAcquireOtherInvestments

1924000000

USD

CY2019

us-gaap

Payments To Acquire Other Investments

PaymentsToAcquireOtherInvestments

1753000000

USD

CY2021

ci

Payments For Proceeds From Property Plant And Equipment

PaymentsForProceedsFromPropertyPlantAndEquipment

1154000000

USD

CY2020

ci

Payments For Proceeds From Property Plant And Equipment

PaymentsForProceedsFromPropertyPlantAndEquipment

1094000000

USD

CY2019

ci

Payments For Proceeds From Property Plant And Equipment

PaymentsForProceedsFromPropertyPlantAndEquipment

1050000000

USD

CY2021

us-gaap

Payments To Acquire Businesses Net Of Cash Acquired

PaymentsToAcquireBusinessesNetOfCashAcquired

1833000000

USD

CY2020

us-gaap

Payments To Acquire Businesses Net Of Cash Acquired

PaymentsToAcquireBusinessesNetOfCashAcquired

139000000

USD

CY2019

us-gaap

Payments To Acquire Businesses Net Of Cash Acquired

PaymentsToAcquireBusinessesNetOfCashAcquired

153000000

USD

CY2021

us-gaap

Proceeds From Divestiture Of Businesses Net Of Cash Divested

ProceedsFromDivestitureOfBusinessesNetOfCashDivested

-61000000

USD

CY2020

us-gaap

Proceeds From Divestiture Of Businesses Net Of Cash Divested

ProceedsFromDivestitureOfBusinessesNetOfCashDivested

5592000000

USD

CY2019

us-gaap

Proceeds From Divestiture Of Businesses Net Of Cash Divested

ProceedsFromDivestitureOfBusinessesNetOfCashDivested

0

USD

CY2021

us-gaap

Payments For Proceeds From Other Investing Activities

PaymentsForProceedsFromOtherInvestingActivities

-97000000

USD

CY2020

us-gaap

Payments For Proceeds From Other Investing Activities

PaymentsForProceedsFromOtherInvestingActivities

-23000000

USD

CY2019

us-gaap

Payments For Proceeds From Other Investing Activities

PaymentsForProceedsFromOtherInvestingActivities

11000000

USD

CY2021

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

-3611000000

USD

CY2020

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

2976000000

USD

CY2019

us-gaap

Net Cash Provided By Used In Investing Activities

NetCashProvidedByUsedInInvestingActivities

-734000000

USD

CY2021

us-gaap

Additions To Contract Holders Funds

AdditionsToContractHoldersFunds

153000000

USD

CY2020

us-gaap

Additions To Contract Holders Funds

AdditionsToContractHoldersFunds

1023000000

USD

CY2019

us-gaap

Additions To Contract Holders Funds

AdditionsToContractHoldersFunds

955000000

USD

CY2021

us-gaap

Withdrawal From Contract Holders Funds

WithdrawalFromContractHoldersFunds

168000000

USD

CY2020

us-gaap

Withdrawal From Contract Holders Funds

WithdrawalFromContractHoldersFunds

979000000

USD

CY2019

us-gaap

Withdrawal From Contract Holders Funds

WithdrawalFromContractHoldersFunds

1097000000

USD

CY2021

ci

Proceeds From Repayments Of Other Short Term Debt

ProceedsFromRepaymentsOfOtherShortTermDebt

975000000

USD

CY2020

ci

Proceeds From Repayments Of Other Short Term Debt

ProceedsFromRepaymentsOfOtherShortTermDebt

60000000

USD

CY2019

ci

Proceeds From Repayments Of Other Short Term Debt

ProceedsFromRepaymentsOfOtherShortTermDebt

-681000000

USD

CY2021

us-gaap

Proceeds From Notes Payable

ProceedsFromNotesPayable

0

USD

CY2020

us-gaap

Proceeds From Notes Payable

ProceedsFromNotesPayable

1398000000

USD

CY2019

us-gaap

Proceeds From Notes Payable

ProceedsFromNotesPayable

0

USD

CY2021

us-gaap

Repayments Of Notes Payable

RepaymentsOfNotesPayable

0

USD

CY2020

us-gaap

Repayments Of Notes Payable

RepaymentsOfNotesPayable

1400000000

USD

CY2019

us-gaap

Repayments Of Notes Payable

RepaymentsOfNotesPayable

0

USD

CY2021

us-gaap

Payments Of Debt Extinguishment Costs

PaymentsOfDebtExtinguishmentCosts

136000000

USD

CY2020

us-gaap

Payments Of Debt Extinguishment Costs

PaymentsOfDebtExtinguishmentCosts

212000000

USD

CY2021

us-gaap

Proceeds From Payments For Other Financing Activities

ProceedsFromPaymentsForOtherFinancingActivities

39000000

USD

CY2019

us-gaap

Payments Of Debt Extinguishment Costs

PaymentsOfDebtExtinguishmentCosts

3000000

USD

CY2021

us-gaap

Repayments Of Long Term Debt

RepaymentsOfLongTermDebt

4578000000

USD

CY2020

us-gaap

Repayments Of Long Term Debt

RepaymentsOfLongTermDebt

8047000000

USD

CY2019

us-gaap

Repayments Of Long Term Debt

RepaymentsOfLongTermDebt

4491000000

USD

CY2021

us-gaap

Proceeds From Issuance Of Long Term Debt

ProceedsFromIssuanceOfLongTermDebt

4260000000

USD

CY2020

us-gaap

Proceeds From Issuance Of Long Term Debt

ProceedsFromIssuanceOfLongTermDebt

3465000000

USD

CY2019

us-gaap

Proceeds From Issuance Of Long Term Debt

ProceedsFromIssuanceOfLongTermDebt

0

USD

CY2021

us-gaap

Payments For Repurchase Of Common Stock

PaymentsForRepurchaseOfCommonStock

7742000000

USD

CY2020

us-gaap

Payments For Repurchase Of Common Stock

PaymentsForRepurchaseOfCommonStock

4042000000

USD

CY2019

us-gaap

Payments For Repurchase Of Common Stock

PaymentsForRepurchaseOfCommonStock

1987000000

USD

CY2021

us-gaap

Proceeds From Issuance Of Common Stock

ProceedsFromIssuanceOfCommonStock

326000000

USD

CY2020

us-gaap

Proceeds From Issuance Of Common Stock

ProceedsFromIssuanceOfCommonStock

376000000

USD

CY2019

us-gaap

Proceeds From Issuance Of Common Stock

ProceedsFromIssuanceOfCommonStock

224000000

USD

CY2021

us-gaap

Payments Of Dividends Common Stock

PaymentsOfDividendsCommonStock

1341000000

USD

CY2020

us-gaap

Payments Of Dividends Common Stock

PaymentsOfDividendsCommonStock

15000000

USD

CY2019

us-gaap

Payments Of Dividends Common Stock

PaymentsOfDividendsCommonStock

15000000

USD

CY2020

us-gaap

Proceeds From Payments For Other Financing Activities

ProceedsFromPaymentsForOtherFinancingActivities

-160000000

USD

CY2019

us-gaap

Proceeds From Payments For Other Financing Activities

ProceedsFromPaymentsForOtherFinancingActivities

-92000000

USD

CY2021

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

-8212000000

USD

CY2020

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

-8533000000

USD

CY2019

us-gaap

Net Cash Provided By Used In Financing Activities

NetCashProvidedByUsedInFinancingActivities

-7187000000

USD

CY2021

us-gaap

Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations

EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations

-65000000

USD

CY2020

us-gaap

Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations

EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations

41000000

USD

CY2019

us-gaap

Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations

EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations

-8000000

USD

CY2021

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

-4697000000

USD

CY2020

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

4834000000

USD

CY2019

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect

1556000000

USD

CY2020Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations

10245000000

USD

CY2019Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations

5411000000

USD

CY2018Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations

3855000000

USD

CY2021Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations

5548000000

USD

CY2020Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations

10245000000

USD

CY2019Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations

5411000000

USD

CY2021Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations

425000000

USD

CY2020Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations

0

USD

CY2019Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations

743000000

USD

CY2021Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

5123000000

USD

CY2020Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

10245000000

USD

CY2019Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

4668000000

USD

CY2021

us-gaap

Income Taxes Paid Net

IncomeTaxesPaidNet

2240000000

USD

CY2020

us-gaap

Income Taxes Paid Net

IncomeTaxesPaidNet

1837000000

USD

CY2019

us-gaap

Income Taxes Paid Net

IncomeTaxesPaidNet

1776000000

USD

CY2021

us-gaap

Interest Paid Net

InterestPaidNet

1253000000

USD

CY2020

us-gaap

Interest Paid Net

InterestPaidNet

1439000000

USD

CY2019

us-gaap

Interest Paid Net

InterestPaidNet

1645000000

USD

CY2019Q4

us-gaap

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations

CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations

743000000

USD

CY2021

us-gaap

Nature Of Operations

NatureOfOperations

Description of Business<div style="margin-bottom:10pt">Cigna Corporation, together with its subsidiaries (either individually or collectively referred to as "Cigna," the "Company," "we," "our" or "us") is a global health services organization with a mission of helping those we serve improve their health, well-being and peace of mind by making health care affordable, predictable and simple. Our subsidiaries offer a differentiated set of pharmacy, medical, behavioral, dental and supplemental products and services. </div><div style="margin-bottom:10pt">The majority of these products are offered through employers and other groups such as governmental and non-governmental organizations, unions and associations. Cigna also offers commercial health and dental insurance and Medicare products to individuals in the United States and selected international markets. In addition to these ongoing operations, Cigna also has certain run-off operations.</div><div style="margin-bottom:10pt">Details of the Company's reporting segments and recent changes are provided below:</div><div style="margin-bottom:10pt">We entered into a definitive agreement in October 2021 to sell our life, accident and supplemental benefits businesses in seven countries to Chubb INA Holdings, Inc. ("Chubb") for $5.75 billion cash (the "Chubb Transaction"). See Note 5 for further information on the classification of these businesses as held for sale. In connection with the pending Chubb Transaction, we revised our business reporting structure. As such, we adjusted our segment reporting effective in the fourth quarter of 2021 so that the results previously reported in the International Markets segment are now reported as follows:</div><div style="padding-left:36pt;text-indent:-18pt">•The businesses to be retained by Cigna are now reported in the newly created International Health operating segment that will be aggregated with our existing U.S. Commercial and U.S. Government operating segments in the renamed Cigna Healthcare reporting segment (previously named U.S. Medical segment).</div><div> </div><div style="padding-left:36pt;text-indent:-18pt">•The businesses to be sold pursuant to the Chubb Transaction are now reported in Other Operations.</div><div> </div><div>Segment results for the years ended December 31, 2020 and 2019 have been restated to conform to the new segment presentation (see Note 23). A full description of our segments follows:</div><div> </div><div style="margin-bottom:10pt">Evernorth includes a broad range of coordinated and point solution health services and capabilities, as well as those from partners across the health care system, in pharmacy solutions, benefits management solutions, care delivery and care management solutions and intelligence solutions, which are provided to health plans, employers, government organizations and health care providers.</div><div style="margin-bottom:10pt">Cigna Healthcare includes U.S. Commercial, U.S. Government and International Health operating segments that provide comprehensive medical and coordinated solutions to clients and customers. U.S. Commercial products and services include medical, pharmacy, behavioral health, dental, vision, health advocacy programs and other products and services for insured and self-insured customers. U.S. Government solutions include Medicare Advantage, Medicare Supplement and Medicare Part D plans for seniors and individual health insurance plans both on and off the public exchanges. International Health solutions include health care coverage in our international markets, as well as health care benefits for globally mobile individuals and employees of multinational organizations. The Cigna Healthcare segment is comprised of the previously named U.S. Medical segment and the businesses to be retained from the previous International Markets segment.</div><div style="margin-bottom:10pt">Other Operations contains the remainder of our business operations, consisting of the following:</div><div style="padding-left:36pt;text-indent:-18pt">•Ongoing business:</div><div style="padding-left:72pt;text-indent:-18pt">•Corporate-Owned Life Insurance ("COLI") offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for the purpose of financing employer-paid future benefit obligations.</div><div style="padding-left:36pt;text-indent:-18pt">•Exiting businesses:</div><div style="padding-left:72pt;text-indent:-18pt">•International Life, Accident and Supplemental Benefits Businesses in seven countries to be sold pursuant to the Chubb Transaction. </div><div style="padding-left:72pt;text-indent:-18pt">•Group Disability and Life. Prior to the sale of the U.S. Group Disability and Life business on December 31, 2020, this operating segment provided group long-term and short-term disability, group life, accident, voluntary and specialty insurance products and related services. </div><div style="padding-left:36pt;text-indent:-18pt">•Run-off businesses:</div><div style="padding-left:72pt;text-indent:-18pt">•Reinsurance: predominantly comprised of guaranteed minimum death benefit ("GMDB") and guaranteed minimum income benefit ("GMIB") business effectively exited through reinsurance with Berkshire Hathaway Life Insurance Company of Nebraska ("Berkshire") in 2013.</div><div style="padding-left:72pt;text-indent:-18pt">•Settlement Annuity business in run-off.</div><div style="margin-bottom:10pt;padding-left:72pt;text-indent:-18pt">•Individual Life Insurance and Annuity and Retirement Benefits businesses: deferred gains from the sales of these businesses.</div><div style="margin-bottom:10pt">Other Operations was previously named Group Disability and Other.</div><div style="margin-bottom:10pt">Corporate reflects amounts not allocated to operating segments, including net interest expense (defined as interest on corporate debt less net investment income on investments not supporting segment and other operations), certain litigation matters, expense associated with our frozen pension plans, charitable contributions, severance, certain overhead and enterprise-wide project costs and intersegment eliminations for products and services sold between segments.</div>

CY2021

us-gaap

Deferred Policy Acquisition Cost Amortization Expense

DeferredPolicyAcquisitionCostAmortizationExpense

478000000

USD

CY2020

us-gaap

Deferred Policy Acquisition Cost Amortization Expense

DeferredPolicyAcquisitionCostAmortizationExpense

502000000

USD

CY2019

us-gaap

Deferred Policy Acquisition Cost Amortization Expense

DeferredPolicyAcquisitionCostAmortizationExpense

483000000

USD

CY2021Q4

ci

Noninsurance Customer Receivables Excluding Pharmaceutical Manufacturers Receivable Before Reclassification To Disposal Group Assets Held For Sale

NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale

6274000000

USD

CY2020Q4

ci

Noninsurance Customer Receivables Excluding Pharmaceutical Manufacturers Receivable

NoninsuranceCustomerReceivablesExcludingPharmaceuticalManufacturersReceivable

5534000000

USD

CY2021Q4

ci

Pharmaceutical Manufacturers Receivable Before Reclassification To Disposal Group Assets Held For Sale

PharmaceuticalManufacturersReceivableBeforeReclassificationToDisposalGroupAssetsHeldForSale

5463000000

USD

CY2020Q4

ci

Pharmaceutical Manufacturer Receivable

PharmaceuticalManufacturerReceivable

4676000000

USD

CY2021Q4

ci

Insurance Customer Receivables Before Reclassification To Disposal Group Assets Held For Sale

InsuranceCustomerReceivablesBeforeReclassificationToDisposalGroupAssetsHeldForSale

2932000000

USD

CY2020Q4

ci

Insurance Customer Receivables

InsuranceCustomerReceivables

1789000000

USD

CY2021Q4

ci

Accounts And Other Receivables Net Current Before Reclassification To Disposal Group Assets Held For Sale

AccountsAndOtherReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale

456000000

USD

CY2020Q4

us-gaap

Accounts And Other Receivables Net Current

AccountsAndOtherReceivablesNetCurrent

192000000

USD

CY2021Q4

ci

Receivables Net Current Before Reclassification To Disposal Group Assets Held For Sale

ReceivablesNetCurrentBeforeReclassificationToDisposalGroupAssetsHeldForSale

15125000000

USD

CY2021Q4

us-gaap

Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net

DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet

54000000

USD

CY2021Q4

us-gaap

Receivables Net Current

ReceivablesNetCurrent

15071000000

USD

CY2020Q4

us-gaap

Receivables Net Current

ReceivablesNetCurrent

12191000000

USD

CY2021Q4

ci

Allowance For Receivables Net Current

AllowanceForReceivablesNetCurrent

1400000000

USD

CY2020Q4

ci

Allowance For Receivables Net Current

AllowanceForReceivablesNetCurrent

1200000000

USD

CY2021Q4

ci

Allowance For Credit Loss Pharmaceutical Manufacturers Receivable

AllowanceForCreditLossPharmaceuticalManufacturersReceivable

926000000

USD

CY2020Q4

ci

Allowance For Credit Loss Pharmaceutical Manufacturers Receivable

AllowanceForCreditLossPharmaceuticalManufacturersReceivable

757000000

USD

CY2021Q4

ci

Allowance For Credit Loss Noninsurance Customer Receivables

AllowanceForCreditLossNoninsuranceCustomerReceivables

321000000

USD

CY2020Q4

ci

Allowance For Credit Loss Noninsurance Customer Receivables

AllowanceForCreditLossNoninsuranceCustomerReceivables

208000000

USD

CY2021Q4

ci

Allowance For Receivables Client Credits

AllowanceForReceivablesClientCredits

186000000

USD

CY2020Q4

ci

Allowance For Receivables Client Credits

AllowanceForReceivablesClientCredits

224000000

USD

CY2021Q4

us-gaap

Allowance For Doubtful Accounts Receivable Current

AllowanceForDoubtfulAccountsReceivableCurrent

60000000

USD

CY2020Q4

us-gaap

Allowance For Doubtful Accounts Receivable Current

AllowanceForDoubtfulAccountsReceivableCurrent

65000000

USD

CY2021

ci

Transaction Related Costs

TransactionRelatedCosts

169000000

USD

CY2021

ci

Transaction Related Costs After Tax

TransactionRelatedCostsAfterTax

71000000

USD

CY2020

ci

Transaction Related Costs

TransactionRelatedCosts

527000000

USD

CY2020

ci

Transaction Related Costs After Tax

TransactionRelatedCostsAfterTax

404000000

USD

CY2019

ci

Transaction Related Costs

TransactionRelatedCosts

552000000

USD

CY2019

ci

Transaction Related Costs After Tax

TransactionRelatedCostsAfterTax

427000000

USD

CY2021

us-gaap

Net Income Loss Available To Common Stockholders Basic

NetIncomeLossAvailableToCommonStockholdersBasic

5365000000

USD

CY2021

us-gaap

Net Income Loss Available To Common Stockholders Basic

NetIncomeLossAvailableToCommonStockholdersBasic

5365000000

USD

CY2020

us-gaap

Net Income Loss Available To Common Stockholders Basic

NetIncomeLossAvailableToCommonStockholdersBasic

8458000000

USD

CY2020

us-gaap

Net Income Loss Available To Common Stockholders Basic

NetIncomeLossAvailableToCommonStockholdersBasic

8458000000

USD

CY2019

us-gaap

Net Income Loss Available To Common Stockholders Basic

NetIncomeLossAvailableToCommonStockholdersBasic

5104000000

USD

CY2019

us-gaap

Net Income Loss Available To Common Stockholders Basic

NetIncomeLossAvailableToCommonStockholdersBasic

5104000000

USD

CY2021

us-gaap

Weighted Average Number Of Shares Issued Basic

WeightedAverageNumberOfSharesIssuedBasic

337962000

shares

CY2021

us-gaap

Weighted Average Number Of Shares Issued Basic

WeightedAverageNumberOfSharesIssuedBasic

337962000

shares

CY2020

us-gaap

Weighted Average Number Of Shares Issued Basic

WeightedAverageNumberOfSharesIssuedBasic

364979000

shares

CY2020

us-gaap

Weighted Average Number Of Shares Issued Basic

WeightedAverageNumberOfSharesIssuedBasic

364979000

shares

CY2019

us-gaap

Weighted Average Number Of Shares Issued Basic

WeightedAverageNumberOfSharesIssuedBasic

375919000

shares

CY2019

us-gaap

Weighted Average Number Of Shares Issued Basic

WeightedAverageNumberOfSharesIssuedBasic

375919000

shares

CY2021

us-gaap

Incremental Common Shares Attributable To Share Based Payment Arrangements

IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

3004000

shares

CY2021

us-gaap

Incremental Common Shares Attributable To Share Based Payment Arrangements

IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

3004000

shares

CY2020

us-gaap

Incremental Common Shares Attributable To Share Based Payment Arrangements

IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

3410000

shares

CY2020

us-gaap

Incremental Common Shares Attributable To Share Based Payment Arrangements

IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

3410000

shares

CY2019

us-gaap

Incremental Common Shares Attributable To Share Based Payment Arrangements

IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

3898000

shares

CY2019

us-gaap

Incremental Common Shares Attributable To Share Based Payment Arrangements

IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

3898000

shares

CY2021

us-gaap

Weighted Average Number Of Shares Issued Basic

WeightedAverageNumberOfSharesIssuedBasic

337962000

shares

CY2021

us-gaap

Incremental Common Shares Attributable To Share Based Payment Arrangements

IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

3004000

shares

CY2021

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

340966000

shares

CY2020

us-gaap

Weighted Average Number Of Shares Issued Basic

WeightedAverageNumberOfSharesIssuedBasic

364979000

shares

CY2020

us-gaap

Incremental Common Shares Attributable To Share Based Payment Arrangements

IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

3410000

shares

CY2020

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

368389000

shares

CY2019

us-gaap

Weighted Average Number Of Shares Issued Basic

WeightedAverageNumberOfSharesIssuedBasic

375919000

shares

CY2019

us-gaap

Incremental Common Shares Attributable To Share Based Payment Arrangements

IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

3898000

shares

CY2019

us-gaap

Weighted Average Number Of Diluted Shares Outstanding

WeightedAverageNumberOfDilutedSharesOutstanding

379817000

shares

CY2021

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

15.87

CY2021

ci

Earnings Per Share Effect Of Dilution

EarningsPerShareEffectOfDilution

-0.14

CY2021

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

15.73

CY2020

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

23.17

CY2020

ci

Earnings Per Share Effect Of Dilution

EarningsPerShareEffectOfDilution

-0.21

CY2020

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

22.96

CY2019

us-gaap

Earnings Per Share Basic

EarningsPerShareBasic

13.58

CY2019

ci

Earnings Per Share Effect Of Dilution

EarningsPerShareEffectOfDilution

-0.14

CY2019

us-gaap

Earnings Per Share Diluted

EarningsPerShareDiluted

13.44

CY2021Q4

us-gaap

Commercial Paper

CommercialPaper

2027000000

USD

CY2020Q4

us-gaap

Commercial Paper

CommercialPaper

1030000000

USD

CY2021Q4

ci

Other Short Term Debt Current Maturities Of Long Term Debt And Lease Obligations Current

OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent

23000000

USD

CY2020Q4

ci

Other Short Term Debt Current Maturities Of Long Term Debt And Lease Obligations Current

OtherShortTermDebtCurrentMaturitiesOfLongTermDebtAndLeaseObligationsCurrent

18000000

USD

CY2021Q4

us-gaap

Debt Current

DebtCurrent

2545000000

USD

CY2020Q4

us-gaap

Debt Current

DebtCurrent

3374000000

USD

CY2021Q4

us-gaap

Other Long Term Debt Noncurrent

OtherLongTermDebtNoncurrent

28000000

USD

CY2020Q4

us-gaap

Other Long Term Debt Noncurrent

OtherLongTermDebtNoncurrent

36000000

USD

CY2021Q4

us-gaap

Long Term Debt And Capital Lease Obligations

LongTermDebtAndCapitalLeaseObligations

31125000000

USD

CY2020Q4

us-gaap

Long Term Debt And Capital Lease Obligations

LongTermDebtAndCapitalLeaseObligations

29545000000

USD

CY2021Q4

us-gaap

Debt Instrument Repurchased Face Amount

DebtInstrumentRepurchasedFaceAmount

4500000000

USD

CY2021

us-gaap

Gains Losses On Extinguishment Of Debt

GainsLossesOnExtinguishmentOfDebt

-141000000

USD

CY2021

ci

Gain Loss On Extinguishment Of Debt Net Of Tax

GainLossOnExtinguishmentOfDebtNetOfTax

-110000000

USD

CY2021

srt

Commercial Paper Average Rate Paid

CommercialPaperAverageRatePaid

0.0026

CY2021Q4

us-gaap

Long Term Debt Maturities Repayments Of Principal In Next Twelve Months

LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths

500000000

USD

CY2021Q4

us-gaap

Long Term Debt Maturities Repayments Of Principal In Year Two

LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo

2967000000

USD

CY2021Q4

us-gaap

Long Term Debt Maturities Repayments Of Principal In Year Three

LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree

1500000000

USD

CY2021Q4

us-gaap

Long Term Debt Maturities Repayments Of Principal In Year Four

LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour

3100000000

USD

CY2021Q4

us-gaap

Long Term Debt Maturities Repayments Of Principal In Year Five

LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive

2300000000

USD

CY2021Q4

us-gaap

Long Term Debt Maturities Repayments Of Principal After Year Five

LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive

21481000000

USD

CY2021

us-gaap

Interest Expense Debt

InterestExpenseDebt

1300000000

USD

CY2020

us-gaap

Interest Expense Debt

InterestExpenseDebt

1400000000

USD

CY2019

us-gaap

Interest Expense Debt

InterestExpenseDebt

1600000000

USD

CY2021Q4

us-gaap

Preferred Stock Shares Authorized

PreferredStockSharesAuthorized

25000000

shares

CY2021Q4

us-gaap

Preferred Stock Par Or Stated Value Per Share

PreferredStockParOrStatedValuePerShare

1

CY2020Q4

us-gaap

Preferred Stock Shares Outstanding

PreferredStockSharesOutstanding

0

shares

CY2021Q4

us-gaap

Preferred Stock Shares Outstanding

PreferredStockSharesOutstanding

0

shares

CY2019Q4

us-gaap

Preferred Stock Shares Outstanding

PreferredStockSharesOutstanding

0

shares

CY2020Q4

us-gaap

Common Stock Par Or Stated Value Per Share

CommonStockParOrStatedValuePerShare

0.01

CY2019Q4

us-gaap

Common Stock Par Or Stated Value Per Share

CommonStockParOrStatedValuePerShare

0.01

CY2021Q4

us-gaap

Common Stock Par Or Stated Value Per Share

CommonStockParOrStatedValuePerShare

0.01

CY2020Q4

us-gaap

Common Stock Shares Authorized

CommonStockSharesAuthorized

600000000

shares

CY2019Q4

us-gaap

Common Stock Shares Authorized

CommonStockSharesAuthorized

600000000

shares

CY2021Q4

us-gaap

Common Stock Shares Authorized

CommonStockSharesAuthorized

600000000

shares

CY2020Q4

us-gaap

Common Stock Shares Outstanding

CommonStockSharesOutstanding

354771000

shares

CY2019Q4

us-gaap

Common Stock Shares Outstanding

CommonStockSharesOutstanding

372531000

shares

CY2018Q4

us-gaap

Common Stock Shares Outstanding

CommonStockSharesOutstanding

380924000

shares

CY2021

us-gaap

Stock Issued During Period Shares Employee Benefit Plan

StockIssuedDuringPeriodSharesEmployeeBenefitPlan

3375000

shares

CY2020

us-gaap

Stock Issued During Period Shares Employee Benefit Plan

StockIssuedDuringPeriodSharesEmployeeBenefitPlan

4142000

shares

CY2019

us-gaap

Stock Issued During Period Shares Employee Benefit Plan

StockIssuedDuringPeriodSharesEmployeeBenefitPlan

3413000

shares

CY2021

us-gaap

Stock Repurchased During Period Shares

StockRepurchasedDuringPeriodShares

35198000

shares

CY2020

us-gaap

Stock Repurchased During Period Shares

StockRepurchasedDuringPeriodShares

21902000

shares

CY2019

us-gaap

Stock Repurchased During Period Shares

StockRepurchasedDuringPeriodShares

11806000

shares

CY2021Q4

us-gaap

Common Stock Shares Outstanding

CommonStockSharesOutstanding

322948000

shares

CY2020Q4

us-gaap

Common Stock Shares Outstanding

CommonStockSharesOutstanding

354771000

shares

CY2019Q4

us-gaap

Common Stock Shares Outstanding

CommonStockSharesOutstanding

372531000

shares

CY2021Q4

us-gaap

Treasury Stock Shares

TreasuryStockShares

71246000

shares

CY2020Q4

us-gaap

Treasury Stock Shares

TreasuryStockShares

35505000

shares

CY2019Q4

us-gaap

Treasury Stock Shares

TreasuryStockShares

13012000

shares

CY2021Q4

us-gaap

Common Stock Shares Issued

CommonStockSharesIssued

394194000

shares

CY2020Q4

us-gaap

Common Stock Shares Issued

CommonStockSharesIssued

390276000

shares

CY2019Q4

us-gaap

Common Stock Shares Issued

CommonStockSharesIssued

385543000

shares

CY2021Q4

us-gaap

Common Stock Dividends Per Share Declared

CommonStockDividendsPerShareDeclared

1.00

CY2021Q2

us-gaap

Common Stock Dividends Per Share Declared

CommonStockDividendsPerShareDeclared

1.00

CY2021Q1

us-gaap

Common Stock Dividends Per Share Declared

CommonStockDividendsPerShareDeclared

1.00

CY2021Q3

us-gaap

Common Stock Dividends Per Share Declared

CommonStockDividendsPerShareDeclared

1.00

CY2021Q1

us-gaap

Common Stock Dividends Per Share Cash Paid

CommonStockDividendsPerShareCashPaid

1.00

CY2021Q1

us-gaap

Dividends Common Stock Cash

DividendsCommonStockCash

345000000

USD

CY2021Q2

us-gaap

Common Stock Dividends Per Share Cash Paid

CommonStockDividendsPerShareCashPaid

1.00

CY2021Q2

us-gaap

Dividends Common Stock Cash

DividendsCommonStockCash

342000000

USD

CY2021Q3

us-gaap

Common Stock Dividends Per Share Cash Paid

CommonStockDividendsPerShareCashPaid

1.00

CY2021Q3

us-gaap

Dividends Common Stock Cash

DividendsCommonStockCash

330000000

USD

CY2021Q4

us-gaap

Common Stock Dividends Per Share Cash Paid

CommonStockDividendsPerShareCashPaid

1.00

CY2021Q4

us-gaap

Dividends Common Stock Cash

DividendsCommonStockCash

324000000

USD

CY2020Q2

us-gaap

Common Stock Dividends Per Share Cash Paid

CommonStockDividendsPerShareCashPaid

0.04

CY2020Q2

us-gaap

Dividends Common Stock Cash

DividendsCommonStockCash

15000000

USD

CY2019Q2

us-gaap

Common Stock Dividends Per Share Cash Paid

CommonStockDividendsPerShareCashPaid

0.04

CY2019Q2

us-gaap

Dividends Common Stock Cash

DividendsCommonStockCash

15000000

USD

CY2021Q3

us-gaap

Stock Repurchase Program Authorized Amount1

StockRepurchaseProgramAuthorizedAmount1

2000000000

USD

CY2021Q3

us-gaap

Accelerated Share Repurchases Settlement Payment Or Receipt

AcceleratedShareRepurchasesSettlementPaymentOrReceipt

-2000000000

USD

CY2021Q3

us-gaap

Treasury Stock Shares Acquired

TreasuryStockSharesAcquired

7700000

shares

CY2021Q3

us-gaap

Treasury Stock Shares Acquired

TreasuryStockSharesAcquired

7700000

shares

CY2021Q4

ci

Accelerated Share Repurchases Stock Settlement

AcceleratedShareRepurchasesStockSettlement

1800000

shares

CY2021Q4

us-gaap

Treasury Stock Shares Acquired

TreasuryStockSharesAcquired

9500000

shares

CY2021Q4

ci

Accelerated Share Repurchases Volume Weighted Average Share Price Less Discount

AcceleratedShareRepurchasesVolumeWeightedAverageSharePriceLessDiscount

209.53

CY2021

us-gaap

Schedule Of Liability For Unpaid Claims And Claims Adjustment Expense

ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense

<div>The Company's insurance and contractholder liabilities were comprised of the following:</div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.288%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.047%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom">December 31, 2021</td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom">December 31, 2020</td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom">(In millions)</td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom">Current</td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom">Non-current</td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom">Total</td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom">Current</td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom">Non-current</td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom">Total</td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom">Contractholder deposit funds</td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom">352 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom">6,702 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom">7,054 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom">350 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom">6,823 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom">7,173 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom">Future policy benefits</td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">312 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">9,194 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">9,506 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">327 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">9,317 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">9,644 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom">Unearned premiums</td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">558 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">418 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">976 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">485 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">394 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">879 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom">Unpaid claims and claim expenses</td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt">Cigna Healthcare</div></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">4,159 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">102 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">4,261 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">3,608 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">87 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">3,695 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom">Other Operations</td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">548 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">180 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">728 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">538 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">223 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">761 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom">Total</td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">5,929 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">16,596 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">22,525 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div>Insurance and contractholder liabilities classified as Liabilities of businesses held for sale (1)</div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">(611)</td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">(4,033)</td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">(4,644)</td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom">Total insurance and contractholder liabilities</td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">5,318 </td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">12,563 </td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">17,881 </td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">5,308 </td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">16,844 </td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">22,152 </td><td style="background-color:#e6e0ec;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:10pt">(1) Amounts classified as Liabilities of businesses held for sale primarily include $3.8 billion of Future policy benefits, $0.4 billion of Unpaid claims and $0.4 billion of Unearned premiums as of December 31, 2021.</div><div>Activity, net of intercompany transactions, in the unpaid claims liability for the Cigna Healthcare segment for the years ended December 31 was as follows:</div><div> </div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.372%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.042%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom">(In millions)</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom">2021</td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom">2020</td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom">2019</td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom">Beginning balance</td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">3,695 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">3,336 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">3,090 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom">Less: Reinsurance and other amounts recoverable</td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">237 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">318 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">280 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom">Beginning balance, net</td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">3,458 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">3,018 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">2,810 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom">Incurred costs related to:</td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom">Current year</td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">31,755 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">27,494 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">26,026 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom">Prior years</td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">(219)</td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">(144)</td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">(180)</td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom">Total incurred</td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">31,536 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">27,350 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">25,846 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom">Paid costs related to:</td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom">Current year</td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">27,929 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">24,187 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">23,176 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom">Prior years</td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">3,065 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">2,723 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">2,462 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom">Total paid</td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">30,994 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">26,910 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">25,638 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom">Ending balance, net</td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">4,000 </td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">3,458 </td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">3,018 </td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom">Add: Reinsurance and other amounts recoverable</td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">261 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">237 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">318 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom">Ending balance</td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom">4,261 </td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom">3,695 </td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom">3,336 </td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt">Liability balance details. The liability details for unpaid claims and claim expenses are as follows. The liability no longer includes the International Health businesses now reported in Cigna Healthcare following our change in segment reporting. Prior year rollforwards have been updated to reflect the segment change. </div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"/><td style="width:78.508%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.095%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.097%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom">(In millions)</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom">December 31, 2021</td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom">December 31, 2020</td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div>Other Operations</div></td><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom">International businesses to be sold</td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom">447 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom">452 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom">Other Operations</td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">281 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">309 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div>Unpaid claims and claim expenses Other Operations</div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">728 </td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">761 </td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div>Activity in the unpaid claims and claim expenses for international businesses held for sale and, prior to the sale, Group Disability and Life (see Note 4 for further information) is presented in the following table. Liabilities associated with Other Operations are excluded because they pertain to obligations for long-duration insurance contracts or, if short-duration, the liabilities have been largely reinsured.</div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.041%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom">(In millions)</td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center">2021 (1)</div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center">2020 </div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom">2019</td></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom">Beginning balance</td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">452 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">5,372 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom">5,039 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom">Less: Reinsurance</td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">45 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">169 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">140 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom">Beginning balance, net</td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">407 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">5,203 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">4,899 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom">Incurred claims related to:</td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom">Current year</td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">982 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">4,205 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">3,958 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom">Prior years:</td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom">Interest accretion</td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">— </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">154 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">152 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom">All other incurred</td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">11 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">48 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">(25)</td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom">Total incurred</td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">993 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">4,407 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">4,085 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom">Paid claims related to:</td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom">Current year</td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">738 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">2,392 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">2,163 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom">Prior years</td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">227 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">1,690 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">1,607 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom">Total paid</td><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">965 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">4,082 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">3,770 </td><td style="background-color:#e6e0ec;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom">Foreign currency</td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">(34)</td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">21 </td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">(11)</td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom"><div>Divestiture of Group Disability and Life business (2)</div></td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">— </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">(5,142)</td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">— </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom">Ending balance, net</td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">401 </td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">407 </td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">5,203 </td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#e6e0ec;padding:2px 1pt;text-align:left;vertical-align:bottom">Add: Reinsurance</td><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">46 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">45 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e6e0ec;padding:0 1pt"/><td colspan="2" style="background-color:#e6e0ec;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom">169 </td><td style="background-color:#e6e0ec;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div>Ending balance </div></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom">447 </td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom">452 </td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom">$</td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom">5,372 </td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div>(1) Includes unpaid claims amounts classified as Liabilities of businesses held for sale. </div><div style="margin-bottom:10pt">(2) Includes Group Disability and Life reserves sold or reinsured to New York Life Insurance Company as part of the sale of the Group Disability and Life business and immaterial retained balances which are now excluded from this table.</div>

CY2021Q4

ci

Policyholder Contract Deposits Current Including Disposal Groups

PolicyholderContractDepositsCurrentIncludingDisposalGroups

352000000

USD

CY2021Q4

ci

Policyholder Contract Deposits Noncurrent Including Disposal Groups

PolicyholderContractDepositsNoncurrentIncludingDisposalGroups

6702000000

USD

CY2021Q4

ci

Policyholder Contract Deposits Including Disposal Groups

PolicyholderContractDepositsIncludingDisposalGroups

7054000000

USD

CY2020Q4

ci

Policyholder Contract Deposit Current

PolicyholderContractDepositCurrent

350000000

USD

CY2020Q4

ci

Policyholder Contract Deposit Noncurrent

PolicyholderContractDepositNoncurrent

6823000000

USD

CY2020Q4

us-gaap

Policyholder Contract Deposits

PolicyholderContractDeposits

7173000000

USD

CY2021Q4

ci

Liability For Future Policy Benefits Current Including Disposal Groups

LiabilityForFuturePolicyBenefitsCurrentIncludingDisposalGroups

312000000

USD

CY2021Q4

ci

Liability For Future Policy Benefits Noncurrent Including Disposal Groups

LiabilityForFuturePolicyBenefitsNoncurrentIncludingDisposalGroups

9194000000

USD

CY2021Q4

ci

Liability For Future Policy Benefits Including Disposal Groups

LiabilityForFuturePolicyBenefitsIncludingDisposalGroups

9506000000

USD

CY2020Q4

ci

Liability For Future Policy Benefit After Reinsurance Current

LiabilityForFuturePolicyBenefitAfterReinsuranceCurrent

327000000

USD

CY2020Q4

ci

Liability For Future Policy Benefit After Reinsurance Noncurrent

LiabilityForFuturePolicyBenefitAfterReinsuranceNoncurrent

9317000000

USD

CY2020Q4

us-gaap

Liability For Future Policy Benefit After Reinsurance

LiabilityForFuturePolicyBenefitAfterReinsurance

9644000000

USD

CY2021Q4

ci

Unearned Premiums Current Including Disposal Groups

UnearnedPremiumsCurrentIncludingDisposalGroups

558000000

USD

CY2021Q4

ci

Unearned Premiums Noncurrent Including Disposal Groups

UnearnedPremiumsNoncurrentIncludingDisposalGroups

418000000

USD

CY2021Q4

ci

Unearned Premiums Including Disposal Groups

UnearnedPremiumsIncludingDisposalGroups

976000000

USD

CY2020Q4

ci

Unearned Premiums Current

UnearnedPremiumsCurrent

485000000

USD

CY2020Q4

ci

Unearned Premiums Noncurrent

UnearnedPremiumsNoncurrent

394000000

USD

CY2020Q4

us-gaap

Unearned Premiums

UnearnedPremiums

879000000

USD

CY2021Q4

ci

Insurance And Contractholder Liabilities Current Including Disposal Groups

InsuranceAndContractholderLiabilitiesCurrentIncludingDisposalGroups

5929000000

USD

CY2021Q4

ci

Insurance And Contractholder Liabilities Noncurrent Including Disposal Groups

InsuranceAndContractholderLiabilitiesNoncurrentIncludingDisposalGroups

16596000000

USD

CY2021Q4

ci

Insurance And Contractholder Liabilities Including Disposal Groups

InsuranceAndContractholderLiabilitiesIncludingDisposalGroups

22525000000

USD

CY2021Q4

ci

Disposal Group Including Discontinued Operation Current Insurance And Contractholder Liabilities

DisposalGroupIncludingDiscontinuedOperationCurrentInsuranceAndContractholderLiabilities

611000000

USD

CY2021Q4

ci

Disposal Group Including Discontinued Operation Noncurrent Insurance And Contractholder Liabilities

DisposalGroupIncludingDiscontinuedOperationNoncurrentInsuranceAndContractholderLiabilities

4033000000

USD

CY2021Q4

ci

Disposal Group Including Discontinued Operation Insurance And Contractholder Liabilities

DisposalGroupIncludingDiscontinuedOperationInsuranceAndContractholderLiabilities

4644000000

USD

CY2021Q4

ci

Insurance And Contractholder Liabilities Current

InsuranceAndContractholderLiabilitiesCurrent

5318000000

USD

CY2021Q4

ci

Insurance And Contractholder Liabilities Noncurrent

InsuranceAndContractholderLiabilitiesNoncurrent

12563000000

USD

CY2021Q4

ci

Insurance And Contractholder Liabilities

InsuranceAndContractholderLiabilities

17881000000

USD

CY2020Q4

ci

Insurance And Contractholder Liabilities Current

InsuranceAndContractholderLiabilitiesCurrent

5308000000

USD

CY2020Q4

ci

Insurance And Contractholder Liabilities Noncurrent

InsuranceAndContractholderLiabilitiesNoncurrent

16844000000

USD

CY2020Q4

ci

Insurance And Contractholder Liabilities

InsuranceAndContractholderLiabilities

22152000000

USD

CY2020Q4

ci

Liability For Future Policy Benefits Attributable To Disposal Groups

LiabilityForFuturePolicyBenefitsAttributableToDisposalGroups

3800000000

USD

CY2020Q4

ci

Liability For Claims And Claims Adjustment Expense Attributable To Disposal Groups

LiabilityForClaimsAndClaimsAdjustmentExpenseAttributableToDisposalGroups

400000000

USD

CY2020Q4

ci

Policyholder Contract Deposits Attributable To Disposal Groups

PolicyholderContractDepositsAttributableToDisposalGroups

400000000

USD

CY2021Q4

ci

Liability For Future Policy Benefits Percent Supported By Assets Held In Trust

LiabilityForFuturePolicyBenefitsPercentSupportedByAssetsHeldInTrust

0.18

CY2021Q4

ci

Reinsurance Recoverables Including Disposal Groups

ReinsuranceRecoverablesIncludingDisposalGroups

5224000000

USD

CY2021Q4

us-gaap

Reinsurance Recoverables Allowance

ReinsuranceRecoverablesAllowance

30000000

USD

CY2021Q4

us-gaap

Reinsurance Recoverables

ReinsuranceRecoverables

5194000000

USD

CY2021Q4

ci

Disposal Group Including Discontinued Operation Reinsurance Recoverables Including Reinsurance Premium Paid

DisposalGroupIncludingDiscontinuedOperationReinsuranceRecoverablesIncludingReinsurancePremiumPaid

95000000

USD

CY2021

us-gaap

Premiums Earned Net

PremiumsEarnedNet

41154000000

USD

CY2020

us-gaap

Premiums Earned Net

PremiumsEarnedNet

42627000000

USD

CY2019

us-gaap

Premiums Earned Net

PremiumsEarnedNet

39714000000

USD

CY2021

us-gaap

Reinsurance Effect On Claims And Benefits Incurred Amount Ceded

ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded

552000000

USD

CY2020

us-gaap

Reinsurance Effect On Claims And Benefits Incurred Amount Ceded

ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded

431000000

USD

CY2019

us-gaap

Reinsurance Effect On Claims And Benefits Incurred Amount Ceded

ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded

395000000

USD

CY2021Q4

ci

Short Term Investments Before Reclassification To Disposal Group Assets Held For Sale

ShortTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale

1264000000

USD

CY2021Q4

ci

Long Term Investments Before Reclassification To Disposal Group Assets Held For Sale

LongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale

23203000000

USD

CY2021Q4

ci

Investments Before Reclassification To Disposal Group Assets Held For Sale

InvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale

24467000000

USD

CY2021Q4

ci

Disposal Group Including Discontinued Operation Current Investments Current

DisposalGroupIncludingDiscontinuedOperationCurrentInvestmentsCurrent

344000000

USD

CY2021Q4

ci

Disposal Group Including Discontinued Operation Noncurrent Investments Current

DisposalGroupIncludingDiscontinuedOperationNoncurrentInvestmentsCurrent

4765000000

USD

CY2021Q4

ci

Disposal Group Including Discontinued Operation Investments

DisposalGroupIncludingDiscontinuedOperationInvestments

5109000000

USD

CY2021Q4

us-gaap

Short Term Investments

ShortTermInvestments

920000000

USD

CY2021Q4

us-gaap

Long Term Investments

LongTermInvestments

18438000000

USD

CY2021Q4

us-gaap

Investments

19358000000

USD

CY2020Q4

us-gaap

Short Term Investments

ShortTermInvestments

1331000000

USD

CY2020Q4

us-gaap

Long Term Investments

LongTermInvestments

23262000000

USD

CY2020Q4

us-gaap

Investments

24593000000

USD

CY2021Q4

ci

Available For Sale Securities Debt Maturities Within One Year Amortized Cost Before Reclassification To Disposal Group Assets Held For Sale

AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale

812000000

USD

CY2021Q4

ci

Available For Sale Securities Debt Maturities Within One Year Fair Value Before Reclassification To Disposal Group Assets Held For Sale

AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale

816000000

USD

CY2021Q4

ci

Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost Before Reclassification To Disposal Group Assets Held For Sale

AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale

5218000000

USD

CY2021Q4

ci

Available For Sale Securities Debt Maturities After One Through Five Years Fair Value Before Reclassification To Disposal Group Assets Held For Sale

AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale

5366000000

USD

CY2021Q4

ci

Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost Before Reclassification To Disposal Group Assets Held For Sale

AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale

5173000000

USD

CY2021Q4

ci

Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value Before Reclassification To Disposal Group Assets Held For Sale

AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale

5453000000

USD

CY2021Q4

ci

Available For Sale Securities Debt Maturities After Ten Years Amortized Cost Before Reclassification To Disposal Group Assets Held For Sale

AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale

4067000000

USD

CY2021Q4

ci

Available For Sale Securities Debt Maturities After Ten Years Fair Value Before Reclassification To Disposal Group Assets Held For Sale

AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale

4805000000

USD

CY2021Q4

ci

Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost Before Reclassification To Disposal Group Assets Held For Sale

AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale

505000000

USD

CY2021Q4

ci

Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value Before Reclassification To Disposal Group Assets Held For Sale

AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValueBeforeReclassificationToDisposalGroupAssetsHeldForSale

518000000

USD

CY2021Q4

ci

Available For Sale Debt Securities Amortized Cost Basis Before Reclassification To Disposal Group Assets Held For Sale

AvailableForSaleDebtSecuritiesAmortizedCostBasisBeforeReclassificationToDisposalGroupAssetsHeldForSale

15775000000

USD

CY2021Q4

ci

Available For Sale Securities Before Reclassification To Disposal Group Assets Held For Sale

AvailableForSaleSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale

16958000000

USD

CY2021Q4

ci

Available For Sale Debt Securities Amortized Cost Basis Before Reclassification To Disposal Group Assets Held For Sale

AvailableForSaleDebtSecuritiesAmortizedCostBasisBeforeReclassificationToDisposalGroupAssetsHeldForSale

15775000000

USD

CY2021Q4

ci

Debt Securities Available For Sale Allowance For Credit Loss Before Reclassification To Disposal Group Assets Held For Sale

DebtSecuritiesAvailableForSaleAllowanceForCreditLossBeforeReclassificationToDisposalGroupAssetsHeldForSale

23000000

USD

CY2021Q4

ci

Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax Before Reclassification To Disposal Group Assets Held For Sale

AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale

1337000000

USD

CY2021Q4

ci

Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax Before Reclassification To Disposal Group Assets Held For Sale

AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTaxBeforeReclassificationToDisposalGroupAssetsHeldForSale

131000000

USD

CY2021Q4

ci

Available For Sale Securities Debt Securities Before Reclassification To Disposal Group Assets Held For Sale

AvailableForSaleSecuritiesDebtSecuritiesBeforeReclassificationToDisposalGroupAssetsHeldForSale

16958000000

USD

CY2020Q4

us-gaap

Available For Sale Debt Securities Amortized Cost Basis

AvailableForSaleDebtSecuritiesAmortizedCostBasis

16220000000

USD

CY2020Q4

us-gaap

Debt Securities Available For Sale Allowance For Credit Loss

DebtSecuritiesAvailableForSaleAllowanceForCreditLoss

26000000

USD

CY2020Q4

us-gaap

Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax

AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax

1990000000

USD

CY2020Q4

us-gaap

Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax

AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax

53000000

USD

CY2020Q4

us-gaap

Available For Sale Securities Debt Securities

AvailableForSaleSecuritiesDebtSecurities

18131000000

USD

CY2021Q4

ci

Debt Securities Available For Sale Unrealized Loss Position Before Reclassification To Disposal Group Assets Held For Sale

DebtSecuritiesAvailableForSaleUnrealizedLossPositionBeforeReclassificationToDisposalGroupAssetsHeldForSale

3890000000

USD

CY2021Q4

ci

Debt Securities Available For Sale Unrealized Loss Position Amortized Cost Before Reclassification To Disposal Group Assets Held For Sale

DebtSecuritiesAvailableForSaleUnrealizedLossPositionAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale

4021000000

USD

CY2021Q4

ci

Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss Before Reclassification To Disposal Group Assets Held For Sale

DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLossBeforeReclassificationToDisposalGroupAssetsHeldForSale

131000000

USD

CY2021Q4

ci

Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Before Reclassification To Disposal Group Assets Held For Sale

AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsBeforeReclassificationToDisposalGroupAssetsHeldForSale

1886

position

CY2020Q4

us-gaap

Debt Securities Available For Sale Unrealized Loss Position

DebtSecuritiesAvailableForSaleUnrealizedLossPosition

1515000000

USD

CY2020Q4

ci

Debt Securities Available For Sale Continuous Unrealized Loss Position Amortized Cost

DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionAmortizedCost

1568000000

USD

CY2020Q4

us-gaap

Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss

DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss

53000000

USD

CY2020Q4

us-gaap

Debt Securities Available For Sale Unrealized Loss Position Number Of Positions

DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions

571

position

CY2021Q4

ci

Equity Securities Fv Ni Cost Before Reclassification To Disposal Group Assets Held For Sale

EquitySecuritiesFvNiCostBeforeReclassificationToDisposalGroupAssetsHeldForSale

257000000

USD

CY2021Q4

ci

Equity Securities Fv Ni Before Reclassification To Disposal Group Assets Held For Sale

EquitySecuritiesFvNiBeforeReclassificationToDisposalGroupAssetsHeldForSale

207000000

USD

CY2020Q4

us-gaap

Equity Securities Fv Ni Cost

EquitySecuritiesFvNiCost

238000000

USD

CY2020Q4

us-gaap

Equity Securities Fvni Noncurrent

EquitySecuritiesFVNINoncurrent

246000000

USD

CY2021Q4

ci

Equity Securities Without Readily Determinable Fair Value Amortized Cost Before Reclassification To Disposal Group Assets Held For Sale

EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale

270000000

USD

CY2021Q4

ci

Equity Securities Without Readily Determinable Fair Value Amount Before Reclassification To Disposal Group Assets Held For Sale

EquitySecuritiesWithoutReadilyDeterminableFairValueAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale

396000000

USD

CY2020Q4

ci

Equity Securities Without Readily Determinable Fair Value Amortized Cost

EquitySecuritiesWithoutReadilyDeterminableFairValueAmortizedCost

225000000

USD

CY2020Q4

us-gaap

Equity Securities Without Readily Determinable Fair Value Amount

EquitySecuritiesWithoutReadilyDeterminableFairValueAmount

255000000

USD

CY2021Q4

ci

Equity Securities Fvni And Without Readily Determinable Fair Value And Hybrid Instruments Amortized Cost Before Reclassification To Disposal Group Assets Held For Sale

EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCostBeforeReclassificationToDisposalGroupAssetsHeldForSale

527000000

USD

CY2021Q4

ci

Equity Securities Fvni And Without Readily Determinable Fair Value And Hybrid Instruments Carrying Amount Before Reclassification To Disposal Group Assets Held For Sale

EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmountBeforeReclassificationToDisposalGroupAssetsHeldForSale

603000000

USD

CY2020Q4

ci

Equity Securities Fvni And Without Readily Determinable Fair Value And Hybrid Instruments Amortized Cost

EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsAmortizedCost

463000000

USD

CY2020Q4

ci

Equity Securities Fvni And Without Readily Determinable Fair Value And Hybrid Instruments Carrying Amount

EquitySecuritiesFVNIAndWithoutReadilyDeterminableFairValueAndHybridInstrumentsCarryingAmount

501000000

USD

CY2021Q4

ci

Unfunded Commitments Percentage Expected To Fund In Next Fiscal Year

UnfundedCommitmentsPercentageExpectedToFundInNextFiscalYear

0.35

CY2021Q4

ci

Other Long Term Investments Before Reclassification To Disposal Group Assets Held For Sale

OtherLongTermInvestmentsBeforeReclassificationToDisposalGroupAssetsHeldForSale

3574000000

USD

CY2020Q4

us-gaap

Other Long Term Investments

OtherLongTermInvestments

2832000000

USD

CY2021Q4

ci

Commitments To Contribute Additional Equity And Capital Before Reclassification To Disposal Group Assets Held For Sale

CommitmentsToContributeAdditionalEquityAndCapitalBeforeReclassificationToDisposalGroupAssetsHeldForSale

2721000000

USD

CY2021

ci

Interest And Dividend Income Operating And Operating Leases Income Statement Lease Revenue

InterestAndDividendIncomeOperatingAndOperatingLeasesIncomeStatementLeaseRevenue

1608000000

USD

CY2020

ci

Interest And Dividend Income Operating And Operating Leases Income Statement Lease Revenue

InterestAndDividendIncomeOperatingAndOperatingLeasesIncomeStatementLeaseRevenue

1296000000

USD

CY2019

ci

Interest And Dividend Income Operating And Operating Leases Income Statement Lease Revenue

InterestAndDividendIncomeOperatingAndOperatingLeasesIncomeStatementLeaseRevenue

1443000000

USD

CY2021

us-gaap

Investment Income Investment Expense

InvestmentIncomeInvestmentExpense

59000000

USD

CY2020

us-gaap

Investment Income Investment Expense

InvestmentIncomeInvestmentExpense

52000000

USD

CY2019

us-gaap

Investment Income Investment Expense

InvestmentIncomeInvestmentExpense

53000000

USD

CY2021

us-gaap

Net Investment Income

NetInvestmentIncome

1549000000

USD

CY2020

us-gaap

Net Investment Income

NetInvestmentIncome

1244000000

USD

CY2019

us-gaap

Net Investment Income

NetInvestmentIncome

1390000000

USD

CY2021

us-gaap

Equity Method Investment Dividends Or Distributions

EquityMethodInvestmentDividendsOrDistributions

568000000

USD

CY2020

us-gaap

Equity Method Investment Dividends Or Distributions

EquityMethodInvestmentDividendsOrDistributions

227000000

USD

CY2019

us-gaap

Equity Method Investment Dividends Or Distributions

EquityMethodInvestmentDividendsOrDistributions

202000000

USD

CY2021

ci

Realized Investment Gain Loss Excluding Impairments

RealizedInvestmentGainLossExcludingImpairments

194000000

USD

CY2020

ci

Realized Investment Gain Loss Excluding Impairments

RealizedInvestmentGainLossExcludingImpairments

186000000

USD

CY2019

ci

Realized Investment Gain Loss Excluding Impairments

RealizedInvestmentGainLossExcludingImpairments

189000000

USD

CY2021

ci

Debt Securities Available For Sale And Commercial Mortgage Loans Allowance For Credit Loss Expense Reversal

DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseReversal

-2000000

USD

CY2020

ci

Debt Securities Available For Sale And Commercial Mortgage Loans Allowance For Credit Loss Expense Reversal

DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseReversal

27000000

USD

CY2019

ci

Debt Securities Available For Sale And Commercial Mortgage Loans Allowance For Credit Loss Expense Reversal

DebtSecuritiesAvailableForSaleAndCommercialMortgageLoansAllowanceForCreditLossExpenseReversal

0

USD

CY2021

ci

Impairments On Investments Total

ImpairmentsOnInvestmentsTotal

0

USD

CY2020

ci

Impairments On Investments Total

ImpairmentsOnInvestmentsTotal

10000000

USD

CY2019

ci

Impairments On Investments Total

ImpairmentsOnInvestmentsTotal

12000000

USD

CY2021

ci

Realized Investment Gain Loss

RealizedInvestmentGainLoss

196000000

USD

CY2020

ci

Realized Investment Gain Loss

RealizedInvestmentGainLoss

149000000

USD

CY2019

ci

Realized Investment Gain Loss

RealizedInvestmentGainLoss

177000000

USD

CY2021Q4

ci

Debt And Equity Securities Classified In Level2 Percentage Before Reclassification To Disposal Group Assets Held For Sale

DebtAndEquitySecuritiesClassifiedInLevel2PercentageBeforeReclassificationToDisposalGroupAssetsHeldForSale

0.94

CY2021Q4

ci

Maximum Percent Level2 Investments Foreign Bonds Broker Quote Before Reclassification To Disposal Group Assets Held For Sale

MaximumPercentLevel2InvestmentsForeignBondsBrokerQuoteBeforeReclassificationToDisposalGroupAssetsHeldForSale

0.01

CY2021Q4

ci

Debt And Equity Securities Classified In Level3 Percentage

DebtAndEquitySecuritiesClassifiedInLevel3Percentage

0.05

CY2021

ci

Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Unrealized Gain Loss Included In Other Comprehensive Income Loss

FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss

-10000000

USD

CY2020

ci

Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Unrealized Gain Loss Included In Other Comprehensive Income Loss

FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetUnrealizedGainLossIncludedInOtherComprehensiveIncomeLoss

-6000000

USD

CY2021Q4

ci

Guaranteed Separate Account Assets Before Reclassification To Disposal Group Assets Held For Sale

GuaranteedSeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale

503000000

USD

CY2020Q4

ci

Guaranteed Separate Account Assets

GuaranteedSeparateAccountAssets

523000000

USD

CY2021Q4

ci

Non Guaranteed Separate Account Assets Classified In Fair Value Hierarchy Before Reclassification To Disposal Group Assets Held For Sale

NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale

7870000000

USD

CY2020Q4

ci

Non Guaranteed Separate Account Assets Classified In Fair Value Hierarchy

NonGuaranteedSeparateAccountAssetsClassifiedInFairValueHierarchy

7880000000

USD

CY2021Q4

ci

Separate Account Assets Classified In Fair Value Hierarchy Before Reclassification To Disposal Group Assets Held For Sale

SeparateAccountAssetsClassifiedInFairValueHierarchyBeforeReclassificationToDisposalGroupAssetsHeldForSale

8373000000

USD

CY2020Q4

ci

Separate Account Assets Classified In Fair Value Hierarchy

SeparateAccountAssetsClassifiedInFairValueHierarchy

8403000000

USD

CY2021Q4

ci

Non Guaranteed Separate Account Assets Priced At Net Asset Value As A Practical Expedient Before Reclassification To Disposal Group Assets Held For Sale

NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedientBeforeReclassificationToDisposalGroupAssetsHeldForSale

842000000

USD

CY2020Q4

ci

Non Guaranteed Separate Account Assets Priced At Net Asset Value As A Practical Expedient

NonGuaranteedSeparateAccountAssetsPricedAtNetAssetValueAsAPracticalExpedient

683000000

USD

CY2021Q4

ci

Separate Account Assets Before Reclassification To Disposal Group Assets Held For Sale

SeparateAccountAssetsBeforeReclassificationToDisposalGroupAssetsHeldForSale

9215000000

USD

CY2021Q4

ci

Disposal Group Including Discontinued Operation Separate Account Assets Current

DisposalGroupIncludingDiscontinuedOperationSeparateAccountAssetsCurrent

878000000

USD

CY2021Q4

us-gaap

Separate Account Assets

SeparateAccountAssets

8337000000

USD

CY2020Q4

us-gaap

Separate Account Assets

SeparateAccountAssets

9086000000

USD

CY2020

ci

Realized Investment Losses Commercial Mortgage Loans Real Estate Entities Certain Equity Securities With No Readily Determinable Fair Value

RealizedInvestmentLossesCommercialMortgageLoansRealEstateEntitiesCertainEquitySecuritiesWithNoReadilyDeterminableFairValue

0

USD

CY2021

ci

Realized Investment Losses Commercial Mortgage Loans Real Estate Entities Certain Equity Securities With No Readily Determinable Fair Value

RealizedInvestmentLossesCommercialMortgageLoansRealEstateEntitiesCertainEquitySecuritiesWithNoReadilyDeterminableFairValue

0

USD

CY2021Q4

us-gaap

Restructuring Charges

RestructuringCharges

168000000

USD

CY2021Q4

ci

Restructuring Charges Net Of Tax Expense

RestructuringChargesNetOfTaxExpense

119000000

USD

CY2021Q4

us-gaap

Business Exit Costs1

BusinessExitCosts1

59000000

USD

CY2021Q4

us-gaap

Severance Costs1

SeveranceCosts1

109000000

USD

CY2021Q4

us-gaap

Severance Costs1

SeveranceCosts1

109000000

USD

CY2021Q4

us-gaap

Payments For Restructuring

PaymentsForRestructuring

6000000

USD

CY2021Q4

us-gaap

Restructuring Reserve

RestructuringReserve

103000000

USD

CY2021

us-gaap

Defined Contribution Plan Cost Recognized

DefinedContributionPlanCostRecognized

268000000

USD

CY2020

us-gaap

Defined Contribution Plan Cost Recognized

DefinedContributionPlanCostRecognized

243000000

USD

CY2019

us-gaap

Defined Contribution Plan Cost Recognized

DefinedContributionPlanCostRecognized

256000000

USD

CY2021Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant

ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant

19100000

shares

CY2020Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant

ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant

20600000

shares

CY2019Q4

us-gaap

Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant

ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant

23200000

shares

CY2021

us-gaap

Allocated Share Based Compensation Expense

AllocatedShareBasedCompensationExpense

268000000

USD

CY2020

us-gaap

Allocated Share Based Compensation Expense

AllocatedShareBasedCompensationExpense

289000000

USD

CY2019

us-gaap

Allocated Share Based Compensation Expense

AllocatedShareBasedCompensationExpense

299000000

USD

CY2021

us-gaap

Employee Service Share Based Compensation Tax Benefit From Compensation Expense

EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense

73000000

USD

CY2020

us-gaap

Employee Service Share Based Compensation Tax Benefit From Compensation Expense

EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense

63000000

USD

CY2019

us-gaap

Employee Service Share Based Compensation Tax Benefit From Compensation Expense

EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense

59000000

USD

CY2020Q4

us-gaap

Goodwill

44648000000

USD

CY2019Q4

us-gaap

Goodwill

44602000000

USD

CY2021

ci

Goodwill Acquired During Period Including Disposal Groups

GoodwillAcquiredDuringPeriodIncludingDisposalGroups

1428000000

USD

CY2020

us-gaap

Goodwill Acquired During Period

GoodwillAcquiredDuringPeriod

29000000

USD

CY2021

ci

Goodwill Foreign Currency Translation Gain Loss Including Disposal Groups

GoodwillForeignCurrencyTranslationGainLossIncludingDisposalGroups

-31000000

USD

CY2020

us-gaap

Goodwill Foreign Currency Translation Gain Loss

GoodwillForeignCurrencyTranslationGainLoss

17000000

USD

CY2021Q4

ci

Goodwill Including Disposal Groups

GoodwillIncludingDisposalGroups

46045000000

USD

CY2021Q4

us-gaap

Disposal Group Including Discontinued Operation Goodwill1

DisposalGroupIncludingDiscontinuedOperationGoodwill1

234000000

USD

CY2021Q4

us-gaap

Goodwill

45811000000

USD

CY2020Q4

us-gaap

Goodwill

44648000000

USD

CY2021Q4

ci

Intangible Assets Gross Excluding Goodwill Including Disposal Groups Assets Held For Sale

IntangibleAssetsGrossExcludingGoodwillIncludingDisposalGroupsAssetsHeldForSale

38844000000

USD

CY2021Q4

ci

Finite Lived Intangible Assets Accumulated Amortization Including Disposal Groups Assets Held For Sale

FiniteLivedIntangibleAssetsAccumulatedAmortizationIncludingDisposalGroupsAssetsHeldForSale

4620000000

USD

CY2021Q4

ci

Intangible Assets Net Excluding Goodwill Including Disposals Groups Assets Held For Sale

IntangibleAssetsNetExcludingGoodwillIncludingDisposalsGroupsAssetsHeldForSale

34224000000

USD

CY2021Q4

ci

Finite Lived Intangible Assets Gross Voba Including Disposal Groups Asset Held For Sale

FiniteLivedIntangibleAssetsGrossVOBAIncludingDisposalGroupsAssetHeldForSale

646000000

USD

CY2021Q4

ci

Finite Lived Intangible Assets Accumulated Amortization Voba Including Disposal Groups Assets Held For Sale

FiniteLivedIntangibleAssetsAccumulatedAmortizationVOBAIncludingDisposalGroupsAssetsHeldForSale

171000000

USD

CY2021Q4

ci

Finite Lived Intangible Assets Net Voba Including Disposal Groups Assets Held For Sale

FiniteLivedIntangibleAssetsNetVOBAIncludingDisposalGroupsAssetsHeldForSale

475000000

USD

CY2021Q4

ci

Intangible Assets Gross Excluding Goodwill Including Voba Including Disposal Groups

IntangibleAssetsGrossExcludingGoodwillIncludingVOBAIncludingDisposalGroups

39490000000

USD

CY2021Q4

ci

Finite Lived Intangible Assets Accumulated Amortization Including Voba Including Disposal Groups

FiniteLivedIntangibleAssetsAccumulatedAmortizationIncludingVOBAIncludingDisposalGroups

4791000000

USD

CY2021Q4

ci

Intangible Assets Net Excluding Goodwill Including Voba Including Disposal Groups

IntangibleAssetsNetExcludingGoodwillIncludingVOBAIncludingDisposalGroups

34699000000

USD

CY2020Q4

us-gaap

Intangible Assets Gross Excluding Goodwill

IntangibleAssetsGrossExcludingGoodwill

38307000000

USD

CY2020Q4

us-gaap

Finite Lived Intangible Assets Accumulated Amortization

FiniteLivedIntangibleAssetsAccumulatedAmortization

3128000000

USD

CY2020Q4

us-gaap

Intangible Assets Net Excluding Goodwill

IntangibleAssetsNetExcludingGoodwill

35179000000

USD

CY2020Q4

ci

Finite Lived Intangible Assets Gross Voba

FiniteLivedIntangibleAssetsGrossVoba

670000000

USD

CY2020Q4

ci

Finite Lived Intangible Assets Accumulated Amortization Voba

FiniteLivedIntangibleAssetsAccumulatedAmortizationVoba

152000000

USD

CY2020Q4

ci

Finite Lived Intangible Assets Net Voba

FiniteLivedIntangibleAssetsNetVoba

518000000

USD

CY2020Q4

ci

Intangible Assets Gross Excluding Goodwill Including Voba

IntangibleAssetsGrossExcludingGoodwillIncludingVoba

38977000000

USD

CY2020Q4

ci

Finite Lived Intangible Assets Accumulated Amortization Including Voba

FiniteLivedIntangibleAssetsAccumulatedAmortizationIncludingVoba

3280000000

USD

CY2020Q4

ci

Intangible Assets Net Excluding Goodwill Including Voba

IntangibleAssetsNetExcludingGoodwillIncludingVoba

35697000000

USD

CY2021Q4

ci

Disposal Group Including Discontinued Operation Value Of Business Acquired

DisposalGroupIncludingDiscontinuedOperationValueOfBusinessAcquired

386000000

USD

CY2021Q4

us-gaap

Disposal Group Including Discontinued Operation Intangible Assets

DisposalGroupIncludingDiscontinuedOperationIntangibleAssets

122000000

USD

CY2021Q4

us-gaap

Indefinite Lived Intangible Assets Excluding Goodwill

IndefiniteLivedIntangibleAssetsExcludingGoodwill

8500000000

USD

CY2020Q4

us-gaap

Indefinite Lived Intangible Assets Excluding Goodwill

IndefiniteLivedIntangibleAssetsExcludingGoodwill

8500000000

USD

CY2021Q4

ci

Property Plant And Equipment Gross Including Disposal Groups

PropertyPlantAndEquipmentGrossIncludingDisposalGroups

10708000000

USD

CY2021Q4

ci

Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Including Disposal Groups

AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentIncludingDisposalGroups

6713000000

USD

CY2021Q4

ci

Property Plant And Equipment Net Including Disposal Groups

PropertyPlantAndEquipmentNetIncludingDisposalGroups

3995000000

USD

CY2021Q4

ci

Disposal Group Including Discontinued Operation Property Plant And Equipment Gross Current

DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentGrossCurrent

424000000

USD

CY2021Q4

ci

Disposal Group Including Discontinued Operation Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Current

DisposalGroupIncludingDiscontinuedOperationAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentCurrent

121000000

USD

CY2021Q4

us-gaap

Disposal Group Including Discontinued Operation Property Plant And Equipment Current

DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent

303000000

USD

CY2021Q4

us-gaap

Property Plant And Equipment Gross

PropertyPlantAndEquipmentGross

10284000000

USD

CY2021Q4

us-gaap

Accumulated Depreciation Depletion And Amortization Property Plant And Equipment

AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

6592000000

USD

CY2021Q4

us-gaap

Property Plant And Equipment Net

PropertyPlantAndEquipmentNet

3692000000

USD

CY2020Q4

us-gaap

Property Plant And Equipment Gross

PropertyPlantAndEquipmentGross

9780000000

USD

CY2020Q4

us-gaap

Accumulated Depreciation Depletion And Amortization Property Plant And Equipment

AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

5575000000

USD

CY2020Q4

us-gaap

Property Plant And Equipment Net

PropertyPlantAndEquipmentNet

4205000000

USD

CY2021

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

2923000000

USD

CY2020

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

2802000000

USD

CY2019

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

3651000000

USD

CY2021Q4

us-gaap

Finite Lived Intangible Assets Amortization Expense Next Twelve Months

FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths

2651000000

USD

CY2021Q4

us-gaap

Finite Lived Intangible Assets Amortization Expense Year Two

FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo

2293000000

USD

CY2021Q4

us-gaap

Finite Lived Intangible Assets Amortization Expense Year Three

FiniteLivedIntangibleAssetsAmortizationExpenseYearThree

1961000000

USD

CY2021Q4

us-gaap

Finite Lived Intangible Assets Amortization Expense Year Four

FiniteLivedIntangibleAssetsAmortizationExpenseYearFour

1792000000

USD

CY2021Q4

us-gaap

Finite Lived Intangible Assets Amortization Expense Year Five

FiniteLivedIntangibleAssetsAmortizationExpenseYearFive

1543000000

USD

CY2021

ci

Finance Lease Cost

FinanceLeaseCost

24000000

USD

CY2020

ci

Finance Lease Cost

FinanceLeaseCost

31000000

USD

CY2021

us-gaap

Operating Lease Cost

OperatingLeaseCost

170000000

USD

CY2020

us-gaap

Operating Lease Cost

OperatingLeaseCost

190000000

USD

CY2019

us-gaap

Operating Lease Cost

OperatingLeaseCost

188000000

USD

CY2021

us-gaap

Finance Lease Right Of Use Asset Amortization

FinanceLeaseRightOfUseAssetAmortization

22000000

USD

CY2020

us-gaap

Finance Lease Right Of Use Asset Amortization

FinanceLeaseRightOfUseAssetAmortization

28000000

USD

CY2019

us-gaap

Finance Lease Right Of Use Asset Amortization

FinanceLeaseRightOfUseAssetAmortization

28000000

USD

CY2021

us-gaap

Finance Lease Interest Expense

FinanceLeaseInterestExpense

2000000

USD

CY2020

us-gaap

Finance Lease Interest Expense

FinanceLeaseInterestExpense

3000000

USD

CY2019

us-gaap

Finance Lease Interest Expense

FinanceLeaseInterestExpense

3000000

USD

CY2019

ci

Finance Lease Cost

FinanceLeaseCost

31000000

USD

CY2021

us-gaap

Variable Lease Cost

VariableLeaseCost

39000000

USD

CY2020

us-gaap

Variable Lease Cost

VariableLeaseCost

48000000

USD

CY2019

us-gaap

Variable Lease Cost

VariableLeaseCost

50000000

USD

CY2021

us-gaap

Lease Cost

LeaseCost

233000000

USD

CY2020

us-gaap

Lease Cost

LeaseCost

269000000

USD

CY2019

us-gaap

Lease Cost

LeaseCost

269000000

USD

CY2021

us-gaap

Gain Loss On Contract Termination

GainLossOnContractTermination

-33000000

USD

CY2021

us-gaap

Operating Lease Payments

OperatingLeasePayments

167000000

USD

CY2020

us-gaap

Operating Lease Payments

OperatingLeasePayments

189000000

USD

CY2019

us-gaap

Operating Lease Payments

OperatingLeasePayments

173000000

USD

CY2021

us-gaap

Finance Lease Interest Payment On Liability

FinanceLeaseInterestPaymentOnLiability

2000000

USD

CY2020

us-gaap

Finance Lease Interest Payment On Liability

FinanceLeaseInterestPaymentOnLiability

3000000

USD

CY2019

us-gaap

Finance Lease Interest Payment On Liability

FinanceLeaseInterestPaymentOnLiability

3000000

USD

CY2021

us-gaap

Finance Lease Principal Payments

FinanceLeasePrincipalPayments

22000000

USD

CY2020

us-gaap

Finance Lease Principal Payments

FinanceLeasePrincipalPayments

26000000

USD

CY2019

us-gaap

Finance Lease Principal Payments

FinanceLeasePrincipalPayments

25000000

USD

CY2021

us-gaap

Right Of Use Asset Obtained In Exchange For Operating Lease Liability

RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability

122000000

USD

CY2020

us-gaap

Right Of Use Asset Obtained In Exchange For Operating Lease Liability

RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability

189000000

USD

CY2019

us-gaap

Right Of Use Asset Obtained In Exchange For Operating Lease Liability

RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability

89000000

USD

CY2021

us-gaap

Right Of Use Asset Obtained In Exchange For Finance Lease Liability

RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability

20000000

USD

CY2020

us-gaap

Right Of Use Asset Obtained In Exchange For Finance Lease Liability

RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability

9000000

USD

CY2019

us-gaap

Right Of Use Asset Obtained In Exchange For Finance Lease Liability

RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability

68000000

USD

CY2021Q4

ci

Operating Lease Right Of Use Asset Including Disposal Groups Assets Held For Sale

OperatingLeaseRightOfUseAssetIncludingDisposalGroupsAssetsHeldForSale

478000000

USD

CY2020Q4

us-gaap

Operating Lease Right Of Use Asset

OperatingLeaseRightOfUseAsset

552000000

USD

CY2021Q4

ci

Operating Lease Liability Current Including Disposal Groups Assets Held For Sale

OperatingLeaseLiabilityCurrentIncludingDisposalGroupsAssetsHeldForSale

159000000

USD

CY2020Q4

us-gaap

Operating Lease Liability Current

OperatingLeaseLiabilityCurrent

152000000

USD

CY2021Q4

ci

Operating Lease Liability Noncurrent Including Disposal Groups Assets Held For Sale

OperatingLeaseLiabilityNoncurrentIncludingDisposalGroupsAssetsHeldForSale

436000000

USD

CY2020Q4

us-gaap

Operating Lease Liability Noncurrent

OperatingLeaseLiabilityNoncurrent

491000000

USD

CY2021Q4

ci

Operating Lease Liability Including Disposal Groups Assets Held For Sale

OperatingLeaseLiabilityIncludingDisposalGroupsAssetsHeldForSale

595000000

USD

CY2020Q4

us-gaap

Operating Lease Liability

OperatingLeaseLiability

643000000

USD

CY2021Q4

us-gaap

Finance Lease Right Of Use Asset Before Accumulated Amortization

FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization

101000000

USD

CY2020Q4

us-gaap

Finance Lease Right Of Use Asset Before Accumulated Amortization

FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization

98000000

USD

CY2021Q4

us-gaap

Finance Lease Right Of Use Asset Accumulated Amortization

FinanceLeaseRightOfUseAssetAccumulatedAmortization

51000000

USD

CY2020Q4

us-gaap

Finance Lease Right Of Use Asset Accumulated Amortization

FinanceLeaseRightOfUseAssetAccumulatedAmortization

46000000

USD

CY2021Q4

us-gaap

Finance Lease Right Of Use Asset

FinanceLeaseRightOfUseAsset

50000000

USD

CY2020Q4

us-gaap

Finance Lease Right Of Use Asset

FinanceLeaseRightOfUseAsset

52000000

USD

CY2021Q4

us-gaap

Finance Lease Liability Current

FinanceLeaseLiabilityCurrent

23000000

USD

CY2020Q4

us-gaap

Finance Lease Liability Current

FinanceLeaseLiabilityCurrent

18000000

USD

CY2021Q4

us-gaap

Finance Lease Liability Noncurrent

FinanceLeaseLiabilityNoncurrent

28000000

USD

CY2020Q4

us-gaap

Finance Lease Liability Noncurrent

FinanceLeaseLiabilityNoncurrent

36000000

USD

CY2021Q4

us-gaap

Finance Lease Liability

FinanceLeaseLiability

51000000

USD

CY2020Q4

us-gaap

Finance Lease Liability

FinanceLeaseLiability

54000000

USD

CY2021Q4

ci

Disposal Group Including Discontinued Operation Operating Lease Right Of Use Assets

DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssets

27000000

USD

CY2021Q4

ci

Disposal Group Including Discontinued Operation Operating Lease Liabilities

DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilities

28000000

USD

CY2021Q4

us-gaap

Operating Lease Weighted Average Remaining Lease Term1

OperatingLeaseWeightedAverageRemainingLeaseTerm1

P5Y

CY2021Q4

us-gaap

Finance Lease Weighted Average Remaining Lease Term1

FinanceLeaseWeightedAverageRemainingLeaseTerm1

P4Y

CY2021Q4

us-gaap

Operating Lease Weighted Average Discount Rate Percent

OperatingLeaseWeightedAverageDiscountRatePercent

0.0281

CY2021Q4

us-gaap

Finance Lease Weighted Average Discount Rate Percent

FinanceLeaseWeightedAverageDiscountRatePercent

0.0313

CY2021Q4

ci

Lessee Operating Lease Liability To Be Paid Year One Including Disposal Groups Assets Held For Sale

LesseeOperatingLeaseLiabilityToBePaidYearOneIncludingDisposalGroupsAssetsHeldForSale

152000000

USD

CY2021Q4

us-gaap

Finance Lease Liability Payments Due Next Twelve Months

FinanceLeaseLiabilityPaymentsDueNextTwelveMonths

25000000

USD

CY2021Q4

ci

Lessee Operating Lease Liability To Be Paid Year Two Including Disposal Groups Assets Held For Sale

LesseeOperatingLeaseLiabilityToBePaidYearTwoIncludingDisposalGroupsAssetsHeldForSale

132000000

USD

CY2021Q4

us-gaap

Finance Lease Liability Payments Due Year Two

FinanceLeaseLiabilityPaymentsDueYearTwo

12000000

USD

CY2021Q4

ci

Lessee Operating Lease Liability To Be Paid Year Three Including Disposal Groups Assets Held For Sale

LesseeOperatingLeaseLiabilityToBePaidYearThreeIncludingDisposalGroupsAssetsHeldForSale

107000000

USD

CY2021Q4

us-gaap

Finance Lease Liability Payments Due Year Three

FinanceLeaseLiabilityPaymentsDueYearThree

6000000

USD

CY2021Q4

ci

Lessee Operating Lease Liability To Be Paid Year Four Including Disposal Groups Assets Held For Sale

LesseeOperatingLeaseLiabilityToBePaidYearFourIncludingDisposalGroupsAssetsHeldForSale

70000000

USD

CY2021Q4

us-gaap

Finance Lease Liability Payments Due Year Four

FinanceLeaseLiabilityPaymentsDueYearFour

3000000

USD

CY2021Q4

ci

Lessee Operating Lease Liability To Be Paid Year Five Including Disposal Groups Assets Held For Sale

LesseeOperatingLeaseLiabilityToBePaidYearFiveIncludingDisposalGroupsAssetsHeldForSale

66000000

USD

CY2021Q4

us-gaap

Finance Lease Liability Payments Due Year Five

FinanceLeaseLiabilityPaymentsDueYearFive

3000000

USD

CY2021Q4

ci

Lessee Operating Lease Liability To Be Paid After Year Five Including Disposal Groups Assets Held For Sale

LesseeOperatingLeaseLiabilityToBePaidAfterYearFiveIncludingDisposalGroupsAssetsHeldForSale

114000000

USD

CY2021Q4

us-gaap

Finance Lease Liability Payments Due After Year Five

FinanceLeaseLiabilityPaymentsDueAfterYearFive

6000000

USD

CY2021Q4

ci

Lessee Operating Lease Liability To Be Paid Including Disposal Groups Assets Held For Sale

LesseeOperatingLeaseLiabilityToBePaidIncludingDisposalGroupsAssetsHeldForSale

641000000

USD

CY2021Q4

us-gaap

Finance Lease Liability Payments Due

FinanceLeaseLiabilityPaymentsDue

55000000

USD

CY2021Q4

ci

Lessee Operating Lease Liability Undiscounted Excess Amount Including Disposal Groups Assets Held For Sale

LesseeOperatingLeaseLiabilityUndiscountedExcessAmountIncludingDisposalGroupsAssetsHeldForSale

46000000

USD

CY2021Q4

us-gaap

Finance Lease Liability Undiscounted Excess Amount

FinanceLeaseLiabilityUndiscountedExcessAmount

4000000

USD

CY2021Q4

ci

Operating Lease Liability Including Disposal Groups Assets Held For Sale

OperatingLeaseLiabilityIncludingDisposalGroupsAssetsHeldForSale

595000000

USD

CY2021Q4

us-gaap

Finance Lease Liability

FinanceLeaseLiability

51000000

USD

CY2021Q4

ci

Disposal Group Including Discontinued Operation Operating Lease Liabilities

DisposalGroupIncludingDiscontinuedOperationOperatingLeaseLiabilities

28000000

USD

CY2021

us-gaap

Statutory Accounting Practices Statutory Net Income Amount

StatutoryAccountingPracticesStatutoryNetIncomeAmount

3400000000

USD

CY2020

us-gaap

Statutory Accounting Practices Statutory Net Income Amount

StatutoryAccountingPracticesStatutoryNetIncomeAmount

4000000000.0

USD

CY2019

us-gaap

Statutory Accounting Practices Statutory Net Income Amount

StatutoryAccountingPracticesStatutoryNetIncomeAmount

3800000000

USD

CY2021Q4

us-gaap

Statutory Capital And Surplus Applying National Association Of Insurance Commissioners Naic Practices

StatutoryCapitalAndSurplusApplyingNationalAssociationOfInsuranceCommissionersNAICPractices

13300000000

USD

CY2020Q4

us-gaap

Statutory Capital And Surplus Applying National Association Of Insurance Commissioners Naic Practices

StatutoryCapitalAndSurplusApplyingNationalAssociationOfInsuranceCommissionersNAICPractices

12900000000

USD

CY2019Q4

us-gaap

Statutory Capital And Surplus Applying National Association Of Insurance Commissioners Naic Practices

StatutoryCapitalAndSurplusApplyingNationalAssociationOfInsuranceCommissionersNAICPractices

13800000000

USD

CY2021Q4

us-gaap

Statutory Accounting Practices Statutory Capital And Surplus Required

StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired

4900000000

USD

CY2021Q4

us-gaap

Assets Held By Insurance Regulators

AssetsHeldByInsuranceRegulators

300000000

USD

CY2021Q4

us-gaap

Statutory Accounting Practices Statutory Amount Available For Dividend Payments

StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPayments

3200000000

USD

CY2021Q4

ci

Statutory Accounting Practices Amount Permitted Lending Authority Of Life Insurance Subsidiary To Parent

StatutoryAccountingPracticesAmountPermittedLendingAuthorityOfLifeInsuranceSubsidiaryToParent

800000000

USD

CY2021Q4

us-gaap

Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries

AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries

12900000000

USD

CY2021Q4

ci

Disposal Group Including Discontinued Operations Statutory Accounting Practices Statutory Capital And Surplus Required

DisposalGroupIncludingDiscontinuedOperationsStatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired

1000000000

USD

CY2021Q4

ci

Disposal Groups Including Discontinued Operations Assets Held By Insurance Regulators

DisposalGroupsIncludingDiscontinuedOperationsAssetsHeldByInsuranceRegulators

40000000

USD

CY2021Q4

ci

Disposal Groups Including Discontinued Operations Statutory Accounting Practices Statutory Amount Available For Dividend Payments

DisposalGroupsIncludingDiscontinuedOperationsStatutoryAccountingPracticesStatutoryAmountAvailableForDividendPayments

200000000

USD

CY2021Q4

ci

Disposal Groups Including Discontinued Operations Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries

DisposalGroupsIncludingDiscontinuedOperationsAmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries

3000000000

USD

CY2021Q4

us-gaap

Retained Earnings Undistributed Earnings From Equity Method Investees

RetainedEarningsUndistributedEarningsFromEquityMethodInvestees

1100000000

USD

CY2021

us-gaap

Current Federal Tax Expense Benefit

CurrentFederalTaxExpenseBenefit

1268000000

USD

CY2020

us-gaap

Current Federal Tax Expense Benefit

CurrentFederalTaxExpenseBenefit

2128000000

USD

CY2019

us-gaap

Current Federal Tax Expense Benefit

CurrentFederalTaxExpenseBenefit

1476000000

USD

CY2021

us-gaap

Current Foreign Tax Expense Benefit

CurrentForeignTaxExpenseBenefit

207000000

USD

CY2020

us-gaap

Current Foreign Tax Expense Benefit

CurrentForeignTaxExpenseBenefit

334000000

USD

CY2019

us-gaap

Current Foreign Tax Expense Benefit

CurrentForeignTaxExpenseBenefit

173000000

USD

CY2021

us-gaap

Current State And Local Tax Expense Benefit

CurrentStateAndLocalTaxExpenseBenefit

112000000

USD

CY2020

us-gaap

Current State And Local Tax Expense Benefit

CurrentStateAndLocalTaxExpenseBenefit

303000000

USD

CY2019

us-gaap

Current State And Local Tax Expense Benefit

CurrentStateAndLocalTaxExpenseBenefit

114000000

USD

CY2021

us-gaap

Current Income Tax Expense Benefit

CurrentIncomeTaxExpenseBenefit

1587000000

USD

CY2020

us-gaap

Current Income Tax Expense Benefit

CurrentIncomeTaxExpenseBenefit

2765000000

USD

CY2019

us-gaap

Current Income Tax Expense Benefit

CurrentIncomeTaxExpenseBenefit

1763000000

USD

CY2021

us-gaap

Deferred Federal Income Tax Expense Benefit

DeferredFederalIncomeTaxExpenseBenefit

-167000000

USD

CY2020

us-gaap

Deferred Federal Income Tax Expense Benefit

DeferredFederalIncomeTaxExpenseBenefit

-217000000

USD

CY2019

us-gaap

Deferred Federal Income Tax Expense Benefit

DeferredFederalIncomeTaxExpenseBenefit

-236000000

USD

CY2021

us-gaap

Deferred Foreign Income Tax Expense Benefit

DeferredForeignIncomeTaxExpenseBenefit

69000000

USD

CY2020

us-gaap

Deferred Foreign Income Tax Expense Benefit

DeferredForeignIncomeTaxExpenseBenefit

11000000

USD

CY2019

us-gaap

Deferred Foreign Income Tax Expense Benefit

DeferredForeignIncomeTaxExpenseBenefit

16000000

USD

CY2021

us-gaap

Deferred State And Local Income Tax Expense Benefit

DeferredStateAndLocalIncomeTaxExpenseBenefit

-122000000

USD

CY2020

us-gaap

Deferred State And Local Income Tax Expense Benefit

DeferredStateAndLocalIncomeTaxExpenseBenefit

-180000000

USD

CY2019

us-gaap

Deferred State And Local Income Tax Expense Benefit

DeferredStateAndLocalIncomeTaxExpenseBenefit

-93000000

USD

CY2021

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

-220000000

USD

CY2020

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

-386000000

USD

CY2019

us-gaap

Deferred Income Tax Expense Benefit

DeferredIncomeTaxExpenseBenefit

-313000000

USD

CY2021

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

1367000000

USD

CY2020

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

2379000000

USD

CY2019

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

1450000000

USD

CY2021

us-gaap

Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate

IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate

1424000000

USD

CY2021

us-gaap

Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate

EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

0.210

CY2020

us-gaap

Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate

IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate

2282000000

USD

CY2020

us-gaap

Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate

EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

0.210

CY2019

us-gaap

Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate

IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate

1380000000

USD

CY2019

us-gaap

Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate

EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate

0.210

CY2021

us-gaap

Income Tax Reconciliation Disposition Of Business

IncomeTaxReconciliationDispositionOfBusiness

0

USD

CY2021

us-gaap

Effective Income Tax Rate Reconciliation Disposition Of Business

EffectiveIncomeTaxRateReconciliationDispositionOfBusiness

0

CY2020

us-gaap

Income Tax Reconciliation Disposition Of Business

IncomeTaxReconciliationDispositionOfBusiness

104000000

USD

CY2020

us-gaap

Effective Income Tax Rate Reconciliation Disposition Of Business

EffectiveIncomeTaxRateReconciliationDispositionOfBusiness

0.010

CY2019

us-gaap

Income Tax Reconciliation Disposition Of Business

IncomeTaxReconciliationDispositionOfBusiness

0

USD

CY2019

us-gaap

Effective Income Tax Rate Reconciliation Disposition Of Business

EffectiveIncomeTaxRateReconciliationDispositionOfBusiness

0

CY2021

ci

Income Tax Reconciliation Permanently Reinvested Foreign Earnings

IncomeTaxReconciliationPermanentlyReinvestedForeignEarnings

33000000

USD

CY2021

ci

Effective Income Tax Rate Reconciliation Permanently Reinvested Foreign Earnings

EffectiveIncomeTaxRateReconciliationPermanentlyReinvestedForeignEarnings

-0.005

CY2020

ci

Income Tax Reconciliation Permanently Reinvested Foreign Earnings

IncomeTaxReconciliationPermanentlyReinvestedForeignEarnings

61000000

USD

CY2020

ci

Effective Income Tax Rate Reconciliation Permanently Reinvested Foreign Earnings

EffectiveIncomeTaxRateReconciliationPermanentlyReinvestedForeignEarnings

-0.006

CY2019

ci

Income Tax Reconciliation Permanently Reinvested Foreign Earnings

IncomeTaxReconciliationPermanentlyReinvestedForeignEarnings

-24000000

USD

CY2019

ci

Effective Income Tax Rate Reconciliation Permanently Reinvested Foreign Earnings

EffectiveIncomeTaxRateReconciliationPermanentlyReinvestedForeignEarnings

0.004

CY2021

ci

Income Tax Reconciliation Health Insurance Industry Tax

IncomeTaxReconciliationHealthInsuranceIndustryTax

0

USD

CY2021

ci

Effective Income Tax Rate Reconciliation Health Insurance Industry Tax

EffectiveIncomeTaxRateReconciliationHealthInsuranceIndustryTax

0

CY2020

ci

Income Tax Reconciliation Health Insurance Industry Tax

IncomeTaxReconciliationHealthInsuranceIndustryTax

93000000

USD

CY2020

ci

Effective Income Tax Rate Reconciliation Health Insurance Industry Tax

EffectiveIncomeTaxRateReconciliationHealthInsuranceIndustryTax

0.009

CY2019

ci

Income Tax Reconciliation Health Insurance Industry Tax

IncomeTaxReconciliationHealthInsuranceIndustryTax

0

USD

CY2019

ci

Effective Income Tax Rate Reconciliation Health Insurance Industry Tax

EffectiveIncomeTaxRateReconciliationHealthInsuranceIndustryTax

0

CY2021

us-gaap

Income Tax Reconciliation State And Local Income Taxes

IncomeTaxReconciliationStateAndLocalIncomeTaxes

-9000000

USD

CY2021

us-gaap

Effective Income Tax Rate Reconciliation State And Local Income Taxes

EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes

-0.001

CY2020

us-gaap

Income Tax Reconciliation State And Local Income Taxes

IncomeTaxReconciliationStateAndLocalIncomeTaxes

24000000

USD

CY2020

us-gaap

Effective Income Tax Rate Reconciliation State And Local Income Taxes

EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes

0.002

CY2019

us-gaap

Income Tax Reconciliation State And Local Income Taxes

IncomeTaxReconciliationStateAndLocalIncomeTaxes

32000000

USD

CY2019

us-gaap

Effective Income Tax Rate Reconciliation State And Local Income Taxes

EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes

0.005

CY2021

us-gaap

Income Tax Reconciliation Other Reconciling Items

IncomeTaxReconciliationOtherReconcilingItems

-15000000

USD

CY2021

us-gaap

Effective Income Tax Rate Reconciliation Other Reconciling Items Percent

EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent

-0.002

CY2020

us-gaap

Income Tax Reconciliation Other Reconciling Items

IncomeTaxReconciliationOtherReconcilingItems

-63000000

USD

CY2020

us-gaap

Effective Income Tax Rate Reconciliation Other Reconciling Items Percent

EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent

-0.006

CY2019

us-gaap

Income Tax Reconciliation Other Reconciling Items

IncomeTaxReconciliationOtherReconcilingItems

14000000

USD

CY2019

us-gaap

Effective Income Tax Rate Reconciliation Other Reconciling Items Percent

EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent

0.002

CY2021

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

1367000000

USD

CY2021

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

0.202

CY2020

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

2379000000

USD

CY2020

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

0.219

CY2019

us-gaap

Income Tax Expense Benefit

IncomeTaxExpenseBenefit

1450000000

USD

CY2019

us-gaap

Effective Income Tax Rate Continuing Operations

EffectiveIncomeTaxRateContinuingOperations

0.221

CY2021Q4

ci

Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Including Disposal Groups Assets Held For Sale

DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsIncludingDisposalGroupsAssetsHeldForSale

304000000

USD

CY2020Q4

us-gaap

Deferred Tax Assets Tax Deferred Expense Compensation And Benefits

DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits

477000000

USD

CY2021Q4

ci

Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Policyholder Liabilities Including Disposal Groups Assets Held For Sale

DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPolicyholderLiabilitiesIncludingDisposalGroupsAssetsHeldForSale

263000000

USD

CY2020Q4

us-gaap

Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Policyholder Liabilities

DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPolicyholderLiabilities

278000000

USD

CY2021Q4

ci

Deferred Tax Assets Operating Loss Carryforwards Including Disposal Groups Assets Held For Sale

DeferredTaxAssetsOperatingLossCarryforwardsIncludingDisposalGroupsAssetsHeldForSale

278000000

USD

CY2020Q4

us-gaap

Deferred Tax Assets Operating Loss Carryforwards

DeferredTaxAssetsOperatingLossCarryforwards

177000000

USD

CY2021Q4

ci

Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other Including Disposal Groups Assets Held For Sale

DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOtherIncludingDisposalGroupsAssetsHeldForSale

412000000

USD

CY2020Q4

us-gaap

Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other

DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther

358000000

USD

CY2021Q4

ci

Deferred Tax Assets Other Including Disposal Groups Assets Held For Sale

DeferredTaxAssetsOtherIncludingDisposalGroupsAssetsHeldForSale

245000000

USD

CY2020Q4

us-gaap

Deferred Tax Assets Other

DeferredTaxAssetsOther

209000000

USD

CY2021Q4

ci

Deferred Tax Assets Gross Including Disposal Groups Assets Held For Sale

DeferredTaxAssetsGrossIncludingDisposalGroupsAssetsHeldForSale

1503000000

USD

CY2020Q4

us-gaap

Deferred Tax Assets Gross

DeferredTaxAssetsGross

1499000000

USD

CY2021Q4

ci

Deferred Tax Assets Valuation Allowance Including Disposal Groups Assets Held For Sale

DeferredTaxAssetsValuationAllowanceIncludingDisposalGroupsAssetsHeldForSale

246000000

USD

CY2020Q4

us-gaap

Deferred Tax Assets Valuation Allowance

DeferredTaxAssetsValuationAllowance

207000000

USD

CY2021Q4

ci

Deferred Tax Assets Net Of Valuation Allowance Including Disposal Groups Assets Held For Sale

DeferredTaxAssetsNetOfValuationAllowanceIncludingDisposalGroupsAssetsHeldForSale

1257000000

USD

CY2020Q4

us-gaap

Deferred Tax Assets Net

DeferredTaxAssetsNet

1292000000

USD

CY2021Q4

ci

Deferred Tax Liabilities Property Plant And Equipment Including Disposal Groups Assets Held For Sale

DeferredTaxLiabilitiesPropertyPlantAndEquipmentIncludingDisposalGroupsAssetsHeldForSale

698000000

USD

CY2020Q4

us-gaap

Deferred Tax Liabilities Property Plant And Equipment

DeferredTaxLiabilitiesPropertyPlantAndEquipment

660000000

USD

CY2021Q4

ci

Deferred Tax Liabilities Goodwill And Intangible Assets Including Disposal Groups Assets Held For Sale

DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIncludingDisposalGroupsAssetsHeldForSale

8726000000

USD

CY2020Q4

us-gaap

Deferred Tax Liabilities Goodwill And Intangible Assets

DeferredTaxLiabilitiesGoodwillAndIntangibleAssets

8989000000

USD

CY2021Q4

ci

Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost Including Disposal Groups Assets Held For Sale

DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCostIncludingDisposalGroupsAssetsHeldForSale

312000000

USD

CY2020Q4

us-gaap

Deferred Tax Liabilities Deferred Expense Deferred Policy Acquisition Cost

DeferredTaxLiabilitiesDeferredExpenseDeferredPolicyAcquisitionCost

289000000

USD

CY2021Q4

ci

Deferred Tax Liabilities Unrealized Gains On Investments And Unrealized Currency Transaction Gains Including Disposal Groups Assets Held For Sale

DeferredTaxLiabilitiesUnrealizedGainsOnInvestmentsAndUnrealizedCurrencyTransactionGainsIncludingDisposalGroupsAssetsHeldForSale

104000000

USD

CY2020Q4

ci

Deferred Tax Liabilities Unrealized Gains On Investments And Unrealized Currency Transaction Gains

DeferredTaxLiabilitiesUnrealizedGainsOnInvestmentsAndUnrealizedCurrencyTransactionGains

171000000

USD

CY2021Q4

ci

Deferred Tax Liabilities Other Including Disposal Groups Assets Held For Sale

DeferredTaxLiabilitiesOtherIncludingDisposalGroupsAssetsHeldForSale

212000000

USD

CY2020Q4

us-gaap

Deferred Tax Liabilities Other

DeferredTaxLiabilitiesOther

122000000

USD

CY2021Q4

ci

Deferred Tax Liabilities Gross Including Disposal Groups Assets Held For Sale

DeferredTaxLiabilitiesGrossIncludingDisposalGroupsAssetsHeldForSale

10052000000

USD

CY2020Q4

us-gaap

Deferred Income Tax Liabilities

DeferredIncomeTaxLiabilities

10231000000

USD

CY2021Q4

ci

Deferred Tax Liabilities Net Including Disposal Group

DeferredTaxLiabilitiesNetIncludingDisposalGroup

8795000000

USD

CY2021Q4

us-gaap

Disposal Group Including Discontinued Operation Deferred Tax Liabilities

DisposalGroupIncludingDiscontinuedOperationDeferredTaxLiabilities

449000000

USD

CY2021Q4

us-gaap

Deferred Tax Liabilities

DeferredTaxLiabilities

8346000000

USD

CY2020Q4

us-gaap

Deferred Tax Liabilities

DeferredTaxLiabilities

8939000000

USD

CY2020Q4

us-gaap

Unrecognized Tax Benefits

UnrecognizedTaxBenefits

1210000000

USD

CY2019Q4

us-gaap

Unrecognized Tax Benefits

UnrecognizedTaxBenefits

1018000000

USD

CY2018Q4

us-gaap

Unrecognized Tax Benefits

UnrecognizedTaxBenefits

928000000

USD

CY2021

us-gaap

Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions

UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions

21000000

USD

CY2020

us-gaap

Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions

UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions

128000000

USD

CY2019

us-gaap

Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions

UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions

68000000

USD

CY2021

us-gaap

Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions

UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions

31000000

USD

CY2020

us-gaap

Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions

UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions

88000000

USD

CY2019

us-gaap

Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions

UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions

29000000

USD

CY2021

us-gaap

Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities

UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities

15000000

USD

CY2020

us-gaap

Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities

UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities

0

USD

CY2019

us-gaap

Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities

UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities

0

USD

CY2021

us-gaap

Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations

UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations

17000000

USD

CY2020

us-gaap

Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations

UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations

24000000

USD

CY2019

us-gaap

Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations

UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations

7000000

USD

CY2021Q4

us-gaap

Unrecognized Tax Benefits

UnrecognizedTaxBenefits

1230000000

USD

CY2020Q4

us-gaap

Unrecognized Tax Benefits

UnrecognizedTaxBenefits

1210000000

USD

CY2019Q4

us-gaap

Unrecognized Tax Benefits

UnrecognizedTaxBenefits

1018000000

USD

CY2021Q4

us-gaap

Unrecognized Tax Benefits Interest On Income Taxes Accrued

UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued

148000000

USD

CY2020Q4

us-gaap

Unrecognized Tax Benefits Interest On Income Taxes Accrued

UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued

127000000

USD

CY2019Q4

us-gaap

Unrecognized Tax Benefits Interest On Income Taxes Accrued

UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued

100000000

USD

CY2021

us-gaap

Guarantees Indemnifications And Warranties Policies

GuaranteesIndemnificationsAndWarrantiesPolicies

Financial Guarantees: Retiree and Life Insurance BenefitsThe Company guarantees that separate account assets will be sufficient to pay certain life insurance or retiree benefits. For the majority of these benefits, the sponsoring employers are primarily responsible for ensuring that assets are sufficient to pay these benefits and are required to maintain assets that exceed a certain percentage of benefit obligations. If employers fail to do so, the Company or an affiliate of the buyer of the retirement benefits business has the right to redirect the management of the related assets to provide for benefit payments.Certain Other GuaranteesThe Company had indemnification obligations as of December 31, 2021 in connection with acquisition and disposition transactions. These indemnification obligations are triggered by the breach of representations or covenants provided by the Company, such as representations for the presentation of financial statements, filing of tax returns, compliance with law or identification of outstanding litigation. These obligations are typically subject to various time limitations, defined by the contract or by operation of law, such as statutes of limitation. In some cases, the maximum potential amount due is subject to contractual limitations based on a percentage of the transaction purchase price, while in other cases limitations are not specified or applicable. The Company does not believe that it is possible to determine the maximum potential amount due under these obligations because not all amounts due under these indemnification obligations are subject to limitation.Guaranty Fund AssessmentsThe Company operates in a regulatory environment that may require its participation in assessments under state insurance guaranty association laws. The Company's exposure to assessments for certain obligations of insolvent insurance companies to policyholders and claimants is based on its share of business written in the relevant jurisdictions.

CY2021

ci

Restructuring Charges Net Of Tax Expense

RestructuringChargesNetOfTaxExpense

119000000

USD

CY2021

us-gaap

Restructuring Charges

RestructuringCharges

168000000

USD

CY2020

ci

Organizational Efficiency Plan Charges Net Of Tax

OrganizationalEfficiencyPlanChargesNetOfTax

24000000

USD

CY2020

ci

Organizational Efficiency Plan Charges

OrganizationalEfficiencyPlanCharges

31000000

USD

CY2019

ci

Organizational Efficiency Plan Charges Net Of Tax

OrganizationalEfficiencyPlanChargesNetOfTax

162000000

USD

CY2019

ci

Organizational Efficiency Plan Charges

OrganizationalEfficiencyPlanCharges

207000000

USD

CY2021

ci

Special Item Charges Debt Extinguishment Costs Net Of Tax

SpecialItemChargesDebtExtinguishmentCostsNetOfTax

110000000

USD

CY2021

ci

Special Item Charges Debt Extinguishment Costs Before Tax

SpecialItemChargesDebtExtinguishmentCostsBeforeTax

141000000

USD

CY2020

ci

Special Item Charges Debt Extinguishment Costs Net Of Tax

SpecialItemChargesDebtExtinguishmentCostsNetOfTax

151000000

USD

CY2020

ci

Special Item Charges Debt Extinguishment Costs Before Tax

SpecialItemChargesDebtExtinguishmentCostsBeforeTax

199000000

USD

CY2019

ci

Special Item Charges Debt Extinguishment Costs Net Of Tax

SpecialItemChargesDebtExtinguishmentCostsNetOfTax

0

USD

CY2019

ci

Special Item Charges Debt Extinguishment Costs Before Tax

SpecialItemChargesDebtExtinguishmentCostsBeforeTax

0

USD

CY2021

ci

Transaction Related Costs After Tax

TransactionRelatedCostsAfterTax

71000000

USD

CY2021

ci

Transaction Related Costs

TransactionRelatedCosts

169000000

USD

CY2020

ci

Transaction Related Costs After Tax

TransactionRelatedCostsAfterTax

404000000

USD

CY2020

ci

Transaction Related Costs

TransactionRelatedCosts

527000000

USD

CY2019

ci

Transaction Related Costs After Tax

TransactionRelatedCostsAfterTax

427000000

USD

CY2019

ci

Transaction Related Costs

TransactionRelatedCosts

552000000

USD

CY2021

ci

Special Item Charge Benefit After Tax Litigation

SpecialItemChargeBenefitAfterTaxLitigation

-21000000

USD

CY2021

ci

Special Item Charge Beforetax Litigation

SpecialItemChargeBeforetaxLitigation

-27000000

USD

CY2020

ci

Special Item Charge Benefit After Tax Litigation

SpecialItemChargeBenefitAfterTaxLitigation

19000000

USD

CY2020

ci

Special Item Charge Beforetax Litigation

SpecialItemChargeBeforetaxLitigation

25000000

USD

CY2019

ci

Special Item Charge Benefit After Tax Litigation

SpecialItemChargeBenefitAfterTaxLitigation

41000000

USD

CY2019

ci

Special Item Charge Beforetax Litigation

SpecialItemChargeBeforetaxLitigation

51000000

USD

CY2021

ci

Special Item Gain Loss On Risk Corridor Allowance Adjustment Net Of Tax

SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentNetOfTax

0

USD

CY2021

ci

Special Item Gain Loss On Risk Corridor Allowance Adjustment Before Taxes

SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentBeforeTaxes

0

USD

CY2020

ci

Special Item Gain Loss On Risk Corridor Allowance Adjustment Net Of Tax

SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentNetOfTax

76000000

USD

CY2020

ci

Special Item Gain Loss On Risk Corridor Allowance Adjustment Before Taxes

SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentBeforeTaxes

101000000

USD

CY2019

ci

Special Item Gain Loss On Risk Corridor Allowance Adjustment Net Of Tax

SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentNetOfTax

0

USD

CY2019

ci

Special Item Gain Loss On Risk Corridor Allowance Adjustment Before Taxes

SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentBeforeTaxes

0

USD

CY2021

ci

Special Item Gain Loss From Contract Adjustment Net Of Tax

SpecialItemGainLossFromContractAdjustmentNetOfTax

0

USD

CY2021

ci

Special Item Gain Loss From Contract Adjustment Before Taxes

SpecialItemGainLossFromContractAdjustmentBeforeTaxes

0

USD

CY2020

ci

Special Item Gain Loss From Contract Adjustment Net Of Tax

SpecialItemGainLossFromContractAdjustmentNetOfTax

155000000

USD

CY2020

ci

Special Item Gain Loss From Contract Adjustment Before Taxes

SpecialItemGainLossFromContractAdjustmentBeforeTaxes

204000000

USD

CY2019

ci

Special Item Gain Loss From Contract Adjustment Net Of Tax

SpecialItemGainLossFromContractAdjustmentNetOfTax

0

USD

CY2019

ci

Special Item Gain Loss From Contract Adjustment Before Taxes

SpecialItemGainLossFromContractAdjustmentBeforeTaxes

0

USD

CY2021

ci

Special Item Gain Loss On Sale Of Business Net Of Tax

SpecialItemGainLossOnSaleOfBusinessNetOfTax

0

USD

CY2021

ci

Special Item Gain Loss On Sale Of Business Before Taxes

SpecialItemGainLossOnSaleOfBusinessBeforeTaxes

0

USD

CY2020

ci

Special Item Gain Loss On Sale Of Business Net Of Tax

SpecialItemGainLossOnSaleOfBusinessNetOfTax

3217000000

USD

CY2020

ci

Special Item Gain Loss On Sale Of Business Before Taxes

SpecialItemGainLossOnSaleOfBusinessBeforeTaxes

4203000000

USD

CY2019

ci

Special Item Gain Loss On Sale Of Business Net Of Tax

SpecialItemGainLossOnSaleOfBusinessNetOfTax

0

USD

CY2019

ci

Special Item Gain Loss On Sale Of Business Before Taxes

SpecialItemGainLossOnSaleOfBusinessBeforeTaxes

0

USD

CY2021

ci

Special Item Gain Or Loss Net Of Tax Attributable To Reportng Entity

SpecialItemGainOrLossNetOfTaxAttributableToReportngEntity

-279000000

USD

CY2021

ci

Special Item Gain Or Loss Before Tax Attributable To Reportng Entity

SpecialItemGainOrLossBeforeTaxAttributableToReportngEntity

-451000000

USD

CY2020

ci

Special Item Gain Or Loss Net Of Tax Attributable To Reportng Entity

SpecialItemGainOrLossNetOfTaxAttributableToReportngEntity

2850000000

USD

CY2020

ci

Special Item Gain Or Loss Before Tax Attributable To Reportng Entity

SpecialItemGainOrLossBeforeTaxAttributableToReportngEntity

3726000000

USD

CY2019

ci

Special Item Gain Or Loss Net Of Tax Attributable To Reportng Entity

SpecialItemGainOrLossNetOfTaxAttributableToReportngEntity

-630000000

USD

CY2019

ci

Special Item Gain Or Loss Before Tax Attributable To Reportng Entity

SpecialItemGainOrLossBeforeTaxAttributableToReportngEntity

-810000000

USD

CY2021

ci

Non Investment Revenue

NonInvestmentRevenue

172529000000

USD

CY2021

us-gaap

Net Investment Income

NetInvestmentIncome

1549000000

USD

CY2021

us-gaap

Revenues

174078000000

USD

CY2021

ci

Realized Investment Gains Losses Equity Method Investments

RealizedInvestmentGainsLossesEquityMethodInvestments

0

USD

CY2021

ci

Segment Revenues

SegmentRevenues

174078000000

USD

CY2021

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

2923000000

USD

CY2021

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

6782000000

USD

CY2021

ci

Income Loss Attributable To Noncontrolling Interest Before Tax

IncomeLossAttributableToNoncontrollingInterestBeforeTax

58000000

USD

CY2021

ci

Realized Investment Gain Loss Including Equity Method Subsidiaries

RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries

196000000

USD

CY2021

us-gaap

Amortization Of Intangible Assets

AmortizationOfIntangibleAssets

1998000000

USD

CY2021

us-gaap

Restructuring Charges

RestructuringCharges

168000000

USD

CY2021

ci

Special Item Charges Debt Extinguishment Costs Before Tax

SpecialItemChargesDebtExtinguishmentCostsBeforeTax

141000000

USD

CY2021

ci

Transaction Related Costs

TransactionRelatedCosts

169000000

USD

CY2021

ci

Special Item Charge Beforetax Litigation

SpecialItemChargeBeforetaxLitigation

-27000000

USD

CY2021

ci

Adjusted Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

8977000000

USD

CY2020

ci

Non Investment Revenue

NonInvestmentRevenue

159157000000

USD

CY2020

us-gaap

Net Investment Income

NetInvestmentIncome

1244000000

USD

CY2020

us-gaap

Revenues

160401000000

USD

CY2020

ci

Realized Investment Gains Losses Equity Method Investments

RealizedInvestmentGainsLossesEquityMethodInvestments

130000000

USD

CY2020

ci

Special Items Increase Decrease To Revenues

SpecialItemsIncreaseDecreaseToRevenues

-204000000

USD

CY2020

ci

Segment Revenues

SegmentRevenues

160067000000

USD

CY2020

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

2802000000

USD

CY2020

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

10868000000

USD

CY2020

ci

Income Loss Attributable To Noncontrolling Interest Before Tax

IncomeLossAttributableToNoncontrollingInterestBeforeTax

37000000

USD

CY2020

ci

Realized Investment Gain Loss Including Equity Method Subsidiaries

RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries

279000000

USD

CY2020

us-gaap

Amortization Of Intangible Assets

AmortizationOfIntangibleAssets

1982000000

USD

CY2020

ci

Organizational Efficiency Plan Charges

OrganizationalEfficiencyPlanCharges

31000000

USD

CY2020

ci

Special Item Charges Debt Extinguishment Costs Before Tax

SpecialItemChargesDebtExtinguishmentCostsBeforeTax

199000000

USD

CY2020

ci

Transaction Related Costs

TransactionRelatedCosts

527000000

USD

CY2020

ci

Special Item Charge Beforetax Litigation

SpecialItemChargeBeforetaxLitigation

25000000

USD

CY2020

ci

Special Item Gain Loss On Risk Corridor Allowance Adjustment Before Taxes

SpecialItemGainLossOnRiskCorridorAllowanceAdjustmentBeforeTaxes

101000000

USD

CY2020

ci

Special Item Gain Loss From Contract Adjustment Before Taxes

SpecialItemGainLossFromContractAdjustmentBeforeTaxes

204000000

USD

CY2020

ci

Special Item Gain Loss On Sale Of Business Before Taxes

SpecialItemGainLossOnSaleOfBusinessBeforeTaxes

4203000000

USD

CY2020

ci

Adjusted Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

8808000000

USD

CY2019

ci

Non Investment Revenue

NonInvestmentRevenue

152176000000

USD

CY2019

us-gaap

Net Investment Income

NetInvestmentIncome

1390000000

USD

CY2019

us-gaap

Revenues

153566000000

USD

CY2019

ci

Revenue Transitioning Clients

RevenueTransitioningClients

13347000000

USD

CY2019

ci

Realized Investment Gains Losses Equity Method Investments

RealizedInvestmentGainsLossesEquityMethodInvestments

44000000

USD

CY2019

ci

Segment Revenues

SegmentRevenues

140175000000

USD

CY2019

us-gaap

Depreciation Depletion And Amortization

DepreciationDepletionAndAmortization

3651000000

USD

CY2019

us-gaap

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

6570000000

USD

CY2019

ci

Income Loss Attributable To Transitioning Clients Pretax

IncomeLossAttributableToTransitioningClientsPretax

1726000000

USD

CY2019

ci

Income Loss Attributable To Noncontrolling Interest Before Tax

IncomeLossAttributableToNoncontrollingInterestBeforeTax

20000000

USD

CY2019

ci

Realized Investment Gain Loss Including Equity Method Subsidiaries

RealizedInvestmentGainLossIncludingEquityMethodSubsidiaries

221000000

USD

CY2019

us-gaap

Amortization Of Intangible Assets

AmortizationOfIntangibleAssets

2949000000

USD

CY2019

ci

Organizational Efficiency Plan Charges

OrganizationalEfficiencyPlanCharges

207000000

USD

CY2019

ci

Transaction Related Costs

TransactionRelatedCosts

552000000

USD

CY2019

ci

Special Item Charge Beforetax Litigation

SpecialItemChargeBeforetaxLitigation

51000000

USD

CY2019

ci

Adjusted Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

AdjustedIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

8362000000

USD

CY2021

us-gaap

Premiums Earned Net

PremiumsEarnedNet

41154000000

USD

CY2020

us-gaap

Premiums Earned Net

PremiumsEarnedNet

42627000000

USD

CY2019

us-gaap

Premiums Earned Net

PremiumsEarnedNet

39714000000

USD

CY2021

ci

Non Investment Revenue

NonInvestmentRevenue

172529000000

USD

CY2020

ci

Non Investment Revenue

NonInvestmentRevenue

159157000000

USD

CY2019

ci

Non Investment Revenue

NonInvestmentRevenue

152176000000

USD

CY2021

ci

Non Investment Revenue

NonInvestmentRevenue

172529000000

USD

CY2020

ci

Non Investment Revenue

NonInvestmentRevenue

159157000000

USD

CY2019

ci

Non Investment Revenue

NonInvestmentRevenue

152176000000

USD

CY2021

dei

Auditor Firm

AuditorFirmId

238

CY2021

dei

Auditor Name

AuditorName

PricewaterhouseCoopers LLP

CY2021

dei

Auditor Location

AuditorLocation

Hartford, Connecticut

Name	View Source	Status
0001739940-22-000007-index-headers.html	Edgar Link	pending
0001739940-22-000007-index.html	Edgar Link	pending
0001739940-22-000007.txt	Edgar Link	pending
0001739940-22-000007-xbrl.zip	Edgar Link	pending
ci-20211231.htm	Edgar Link	pending
ci-20211231.xsd	Edgar Link	pending
ci-20211231_cal.xml	Edgar Link	unprocessable
ci-20211231_def.xml	Edgar Link	unprocessable
ci-20211231_g1.jpg	Edgar Link	pending
ci-20211231_g2.jpg	Edgar Link	pending
ci-20211231_htm.xml	Edgar Link	completed
ci-20211231_lab.xml	Edgar Link	unprocessable
ci-20211231_pre.xml	Edgar Link	unprocessable
exh1017adirectorcompensati.htm	Edgar Link	pending
exh1017bdirectorcompensati.htm	Edgar Link	pending
exh1030bwentworthretiremen.htm	Edgar Link	pending
exh1030cwentworthadvisorya.htm	Edgar Link	pending
exh1036bmandersretirementa.htm	Edgar Link	pending
exh1036cmandersadvisoryagr.htm	Edgar Link	pending
exh32amendedandrestatedbyl.htm	Edgar Link	pending
exhibit21xsubsidiariesofth.htm	Edgar Link	pending
exhibit23xauditorconsent20.htm	Edgar Link	pending
exhibit311-2021_q4.htm	Edgar Link	pending
exhibit312-2021_q4.htm	Edgar Link	pending
exhibit321-2021_q4.htm	Edgar Link	pending
exhibit322-2021_q4.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R121.htm	Edgar Link	pending
R122.htm	Edgar Link	pending
R123.htm	Edgar Link	pending
R124.htm	Edgar Link	pending
R125.htm	Edgar Link	pending
R126.htm	Edgar Link	pending
R127.htm	Edgar Link	pending
R128.htm	Edgar Link	pending
R129.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R130.htm	Edgar Link	pending
R131.htm	Edgar Link	pending
R132.htm	Edgar Link	pending
R133.htm	Edgar Link	pending
R134.htm	Edgar Link	pending
R135.htm	Edgar Link	pending
R136.htm	Edgar Link	pending
R137.htm	Edgar Link	pending
R138.htm	Edgar Link	pending
R139.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R140.htm	Edgar Link	pending
R141.htm	Edgar Link	pending
R142.htm	Edgar Link	pending
R143.htm	Edgar Link	pending
R144.htm	Edgar Link	pending
R145.htm	Edgar Link	pending
R146.htm	Edgar Link	pending
R147.htm	Edgar Link	pending
R148.htm	Edgar Link	pending
R149.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R150.htm	Edgar Link	pending
R151.htm	Edgar Link	pending
R152.htm	Edgar Link	pending
R153.htm	Edgar Link	pending
R154.htm	Edgar Link	pending
R155.htm	Edgar Link	pending
R156.htm	Edgar Link	pending
R157.htm	Edgar Link	pending
R158.htm	Edgar Link	pending
R159.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R160.htm	Edgar Link	pending
R161.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CI
Cigna Group Stock $ci

2022 Q1 Form 10-K Financial Statement

#000173994022000007 Filed on February 24, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CI Cigna Group Stock $ci

2022 Q1 Form 10-K Financial Statement

#000173994022000007 Filed on February 24, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CI
Cigna Group Stock $ci